Erythrocyte Disorders

Gaston, MH, Verter, JI, Woods, G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314(25):1593–9.Google Scholar

Vichinsky, E, Hurst, D, Earles, A, Kleman, K, Lubin, B. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988;81(6):749–55.CrossRef Google Scholar PubMed

Cowan, MJ, Neven, B, Cavazanna-Calvo, M, Fischer, A, Puck, J. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases. Biol Blood Marrow Transplant 2008;14(1 Suppl 1):73–5.CrossRef Google Scholar PubMed

Myers, LA, Patel, DD, Puck, JM, Buckley, RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99(3):872–8.Google Scholar

Guthrie, R, Susi, A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338–43.CrossRef Google Scholar PubMed

Levy, HL. Genetic screening. Adv Hum Genet 1973;4:1–104.Google Scholar PubMed

Dussault, JH, Coulombe, P, Laberge, C, et al. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 1975;86(5):670–4.CrossRef Google Scholar PubMed

Itano, HA, Pauling, L. A rapid diagnostic test for sickle cell anemia. Blood 1949;4(1):66–8.Google Scholar

Nalbandian, RM, Nichols, BM, Camp, FR, Jr., et al. Dithionite tube test – a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin. Clin Chem 1971;17(10):1028–32.Google Scholar

Nichols, BM, Nalbandian, RM, Henry, RL, Wolf, PL, Camp, FR, Jr. Murayama test for hemoglobin S: Simplification in technique. Clin Chem 1971;17(10):1059–60.Google Scholar

Hicksg, EJ, Griep, JA, Nordschow, CD. Comparison of results for three method of hemoglobin S identification. Clin Chem 1973;19(5):533–5.Google Scholar

Garrick, MD, Dembure, P, Guthrie, R. Sickle-cell anemia and other hemoglobinopathies: Procedures and strategy for screening employing spots of blood on filter paper as specimens. N Engl J Med 1973;288(24):1265–8.CrossRef Google Scholar PubMed

Kohn, J. Separation of haemoglobins on cellulose acetate. J Clin Pathol 1969;22(1):109–11.Google Scholar

Benson, JM, Therrell, BL, Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol 2010;34(2):134–44.Google Scholar

Rashed, MS, Ozand, PT, Bucknall, MP, Little, D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38(3):324–31.Google Scholar

Moat, SJ, Rees, D, King, L, et al. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: Implementation of a protocol to identify only the disease states of sickle cell disease. Clin Chem 2014;60(2):373–80.Google Scholar

Schmidt, RM, Holland, S. Standardization in abnormal hemoglobin detection. An evaluation of hemoglobin electrophoresis kits. Clin Chem 1974;20(5):591–4.Google Scholar

Schmidt, RM, Brosious, EM. Evaluation of proficiency in the performance of tests for abnormal hemoglobins. Am J Clin Pathol 1974;62(5):664–9.CrossRef Google Scholar PubMed

De Jesus, VR, Mei, JV, Bell, CJ, Hannon, WH. Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention. Semin Perinatol 2010;34(2):125–33.Google Scholar

De Jesus, VR, Mei, JV, Cordovado, SK, Cuthbert, CD. The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five year experience assuring newborn screening laboratory quality. Int J Neonatal Screen 2015;1(1):13–26.Google Scholar

Gaston, M, Rosse, WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982;4(2):197–201.Google Scholar

Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 1987;258(9):1205–9.Google Scholar

Therrell, BL, Jr., Lloyd-Puryear, MA, Eckman, JR, Mann, MY. Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades. Semin Perinatol 2015;39(3):238–51.Google Scholar

Watson, MS, Mann, MY, Lloyd, -Puryear, MA, et al., American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: Toward a uniform screening panel and system: Executive summary. Pediatrics 2006; 117 (5 Pt 2): S296–307.Google Scholar

Koopmans, J, Hiraki, S, Ross, LF. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: Implications for policy. Am J Med Genet A 2006;140(21):2305–11.Google Scholar

Natowicz, M. Newborn screening: Setting evidence-based policy for protection. N Engl J Med 2005;353(9):867–70.CrossRef Google Scholar PubMed

Botkin, JR, Clayton, EW, Fost, NC, et al. Newborn screening technology: Proceed with caution. Pediatrics 2006;117(5):1793–9.Google Scholar

Heredero-Baute, L. Community-based program for the diagnosis and prevention of genetic disorders in Cuba: Twenty years of experience.Community Genet 2004;7(2–3):130–6.Google Scholar PubMed

Therrell, BL, Padilla, CD, Loeber, JG, et al. Current status of newborn screening worldwide: 2015.Semin Perinatol 2015;39(3):171–87.CrossRef Google Scholar PubMed

Fernandes, AP, Januario, JN, Cangussu, CB, Macedo, DL, Viana, MB. Mortality of children with sickle cell disease: A population study. J Pediatr 2010;86(4):279–84.Google Scholar

Sabarense, AP, Lima, GO, Silva, LM, Viana, MB. Survival of children with sickle cell disease in the comprehensive newborn screening programme in Minas Gerais, Brazil. Paediatr Int Child Health 2015;35(4):329–32.Google Scholar

Silva-Pinto, AC, Alencar de Queiroz, MC, Antoniazzo, Zamaro, PJ, Arruda, M, Pimentel, dos Santos, H. The neonatal screening program in Brazil, focus on sickle cell disease (SCD).Int J Neonatal Screen 2019;5(1):11.Google Scholar

Piel, FB, Hay, SI, Gupta, S, Weatherall, DJ, Williams, TN. Global burden of sickle cell anaemia in children under five, 2010–2050: Modelling based on demographics, excess mortality, and interventions. PLoS Med 2013;10(7):e1001484.CrossRef Google Scholar PubMed

Upadhye, DS, Jain, DL, Trivedi, YL, et al. Neonatal screening and the clinical outcome in children with sickle cell disease in central India. PLoS One 2016;11(1):e0147081.CrossRef Google Scholar PubMed

Dixit, S, Sahu, P, Kar, SK, Negi, S. Identification of the hot-spot areas for sickle cell disease using cord blood screening at a district hospital: An Indian perspective. J Community Genet 2015;6(4):383–7.Google Scholar

Upadhye, D, Das, RS, Ray, J, et al. Newborn screening for hemoglobinopathies and red cell enzymopathies in Tripura State: A malaria-endemic state in northeast India. Hemoglobin 2018;42(1):43–6.Google Scholar

Panigrahi, S, Patra, PK, Khodiar, PK. Neonatal screening of sickle cell anemia: A preliminary report. Indian J Pediatr 2012;79(6):747–50.Google Scholar

Howson, CP, Cedergren, B, Giugliani, R, et al. Universal newborn screening: A roadmap for action. Mol Genet Metab 2018;124(3):177–83.Google Scholar

McGann, PT, Ferris, MG, Ramamurthy, U, et al. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola. Am J Hematol 2013;88(12):984–9.Google Scholar

McGann, PT, Grosse, SD, Santos, B, et al. A cost-effectiveness analysis of a pilot neonatal screening program for sickle cell anemia in the Republic of Angola. J Pediatr 2015;167(6):1314–9.Google Scholar

Ndeezi, G, Kiyaga, C, Hernandez, AG, et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): A cross-sectional study. Lancet Glob Health 2016;4(3):e195–200.Google Scholar

McGann, PT, Hernandez, AG, Ware, RE. Sickle cell anemia in sub-Saharan Africa: Advancing the clinical paradigm through partnerships and research. Blood 2017;129(2):155–61.Google Scholar

Streetly, A, Sisodia, R, Dick, M, et al. Evaluation of newborn sickle cell screening programme in England: 2010–2016. Arch Dis Child 2018;103(7):648–53.Google Scholar

Holtzman, NA. Newborn screening for severe combined immunodeficiency: Progress and challenges. JAMA 2014;312(7):701–2.Google Scholar

Adams, SP, Rashid, S, Premachandra, T, et al. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J Clin Immunol 2014;34(3):323–30.CrossRef Google Scholar PubMed

Audrain, M, Thomas, C, Mirallie, S, et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin Immunol 2014;150(2):137–9.Google Scholar

Somech, R, Lev, A, Simon, AJ, et al. Newborn screening for severe T and B cell immunodeficiency in Israel: A pilot study. Isr Med Assoc J 2013;15(8):404–9.Google Scholar

Chien, YH, Chiang, SC, Chang, KL, et al. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J Formos Med Assoc 2015;114(1):12–6.CrossRef Google Scholar PubMed

Kwan, A, Church, JA, Cowan, MJ, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years. J Allergy Clin Immunol 2013;132(1):140–50.CrossRef Google Scholar PubMed

Hassell, KL. Population estimates of sickle cell disease in the US. Am J Prev Med 2010;38(4 Suppl):S512–21.CrossRef Google Scholar

Modell, B, Darlison, M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480–7.Google Scholar

Weatherall, DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010;115(22):4331–6.Google Scholar

Pasvol, G, Weatherall, DJ, Wilson, RJ. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria.Nature 1978;274(5672):701–3.Google Scholar

Allen, SJ, O’Donnell, A, Alexander, ND, et al. Alpha+–thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997;94(26):14736–41.Google Scholar

Taylor, SM, Parobek, CM, Fairhurst, RM. Haemoglobinopathies and the clinical epidemiology of malaria: A systematic review and meta-analysis. Lancet Infect Dis 2012;12(6):457–68.Google Scholar

Williams, TN, Mwangi, TW, Wambua, S, et al. Negative epistasis between the malaria-protective effects of alpha+–thalassemia and the sickle cell trait. Nat Genet 2005;37(11):1253–7.Google Scholar

Sundd, P, Gladwin, MT, Novelli, EM. Pathophysiology of sickle cell disease. Annu Rev Pathol 2019;14:263–92.Google Scholar

Serjeant, GR. Natural history and determinants of clinical severity of sickle cell disease. Curr Opin Hematol 1995;2(2):103–8.Google Scholar

Chui, DH, Waye, JS. Hydrops fetalis caused by alpha-thalassemia: An emerging health care problem. Blood 1998;91(7):2213–22.Google Scholar

Fucharoen, S, Viprakasit, V. Hb H disease: Clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program 2009;2009(1):26–34.Google Scholar

Lal, A, Goldrich, ML, Haines, DA, et al. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med 2011;364(8):710–18.Google Scholar

Menzel, S, Garner, C, Rooks, H, Spector, TD, Thein, SL. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol 2013;160(1):101–5.Google Scholar

Olivieri, NF. The beta-thalassemias. New Engl J Med 1999;341(2):99–109.Google Scholar

Ho, PJ, Hall, GW, Luo, LY, Weatherall, DJ, Thein, SL. Beta-thalassaemia intermedia: Is it possible consistently to predict phenotype from genotype? Br J Haematol 1998;100(1):70–8.Google Scholar

Ho, PJ, Wickramasinghe, SN, Rees, DC, et al. Erythroblastic inclusions in dominantly inherited beta thalassemias. Blood 1997;89(1):322–8.Google Scholar

Efremov, DG, Efremov, GD, Zisovski, N, et al. Variation in clinical severity among patients with Hb Lepore-Boston-beta-thalassaemia is related to the type of beta-thalassaemia. Br J Haematol 1988;68(3):351–5.Google Scholar

Thein, SL. Genetic modifiers of beta-thalassemia. Haematologica 2005;90(5):649–60.Google Scholar

Higgs, DR, Clegg, JB, Weatherall, DJ, Serjeant, BE, Serjeant, GR. Interaction of the alpha alpha alpha globin gene haplotype and sickle haemoglobin. Br J Haematol 1984;57(4):671–8.Google Scholar

Cappellini, MD, Fiorelli, G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371(9606):64–74.Google Scholar

Kaplan, M, Renbaum, P, Levy-Lahad, E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997;94(22):12128–32.Google Scholar

Frank, JE. Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72(7):1277–82.Google Scholar

Kaplan, M, Hammerman, C. Glucose-6-phosphate dehydrogenase deficiency: A hidden risk for kernicterus. Semin Perinatol 2004;28(5):356–64.Google Scholar

Slusher, TM, Vreman, HJ, McLaren, DW, et al. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995;126(1):102–8.Google Scholar

Al-Mousa, H, Al-Saud, B. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: Epidemiology, diagnosis, and care. Front Immunol 2017;8:678.Google Scholar

Griffith, LM, Cowan, MJ, Notarangelo, LD, et al. Improving cellular therapy for primary immune deficiency diseases: Recognition, diagnosis, and management. J Allergy Clin Immunol 2009;124(6):1152–60 e12.Google Scholar

Cossu, F. Genetics of SCID. Ital J Pediatr 2010;36:76.CrossRef Google Scholar PubMed

Shearer, WT, Dunn, E, Notarangelo, LD, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 2014;133(4):1092–8.Google Scholar

Pai, SY, Logan, BR, Griffith, LM, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med 2014;371(5):434–46.Google Scholar

Sarmiento, JD, Villada, F, Orrego, JC, Franco, JL, Trujillo-Vargas, CM. Adverse events following immunization in patients with primary immunodeficiencies. Vaccine 2016;34(13):1611–6.Google Scholar

Chong, SS, Boehm, CD, Higgs, DR, Cutting, GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000;95(1):360–2.Google Scholar

Harteveld, CL, Refaldi, C, Cassinerio, E, Cappellini, MD, Giordano, PC. Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis 2008;40(3):312–16.Google Scholar

Old, JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest 2007;67(1):71–86.CrossRef Google Scholar PubMed

Bond, M, Hunt, B, Flynn, B, et al. Towards a point-of-care strip test to diagnose sickle cell anemia. PLoS One 2017;12(5):e0177732.Google Scholar

Kumar, AA, Chunda-Liyoka, C, Hennek, JW, et al. Evaluation of a density-based rapid diagnostic test for sickle cell disease in a clinical setting in Zambia. PLoS One 2014;9(12):e114540.CrossRef Google Scholar

Yang, X, Kanter, J, Piety, NZ, et al. A simple, rapid, low-cost diagnostic test for sickle cell disease. Lab Chip 2013;13(8):1464–7.Google Scholar

Kanter, J, Telen, MJ, Hoppe, C, et al. Validation of a novel point of care testing device for sickle cell disease. BMC Med 2015;13:225.Google Scholar

McGann, PT, Schaefer, BA, Paniagua, M, Howard, TA, Ware, RE. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease. Am J Hematol 2016;91(2):205–10.Google Scholar

Quinn, CT, Paniagua, MC, DiNello, RK, Panchal, A, Geisberg, M. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies. Br J Haematol 2016;175(4):724–32.Google Scholar

Ung, R, Alapan, Y, Hasan, MN, et al. Point-of-care screening for sickle cell disease by a mobile micro-electrophoresis platform. Blood 2015;126(23).Google Scholar

Grosveld, F, Antoniou, M, Berry, M, et al. The regulation of human globin gene switching. Philos Trans R Soc Lond B Biol Sci 1993;339(1288):183–91.Google Scholar

Colombo, B, Kim, B, Atencio, RP, Molina, C, Terrenato, L. The pattern of fetal haemoglobin disappearance after birth. Br J Haematol 1976;32(1):79–87.Google Scholar

Davis, LR. Changing blood picture in sickle-cell anaemia from shortly after birth to adolescence. J Clin Pathol 1976;29(10):898–901.Google Scholar

Hustace, T, Fleisher, JM, Sanchez Varela, AM, Podda, A, Alvarez, O. Increased prevalence of false positive hemoglobinopathy newborn screening in premature infants. Pediatr Blood Cancer 2011;57(6):1039–43.Google Scholar

Hoppe, CC. Newborn screening for non-sickling hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2009; 2009:19–25.Google Scholar

Reed, W, Lane, PA, Lorey, F, et al. Sickle-cell disease not identified by newborn screening because of prior transfusion. J Pediatr 2000;136(2):248–50.Google Scholar

Yates, AM, Mortier, NA, Hyde, KS, Hankins, JS, Ware, RE. The diagnostic dilemma of congenital unstable hemoglobinopathies. Pediatr Blood Cancer 2010;55(7):1393–5.Google Scholar

Alauddin, H, Langa, M, Mohd Yusoff, M, et al. Detection of alpha-thalassaemia in neonates on cord blood and dried blood spot samples by capillary electrophoresis. Malays J Pathol 2017;39(1):17–23.Google Scholar

Frempong, T, Pearson, HA. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut. Conn Med 2007;71(1):9–12.Google Scholar

Okpala, I, Thomas, V, Westerdale, N, et al. The comprehensiveness care of sickle cell disease. Eur J Haematol 2002;68(3):157–62.Google Scholar

Fogel, BN, Nguyen, HLT, Smink, G, Sekhar, DL. Variability in state-based recommendations for management of alpha thalassemia trait and silent carrier detected on the newborn screen. J Pediatr 2018;195:283–7.CrossRef Google Scholar PubMed

Michlitsch, J, Azimi, M, Hoppe, C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009;52(4):486–90.Google Scholar

Watchko, JF, Kaplan, M, Stark, AR, Stevenson, DK, Bhutani, VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol 2013;33(7):499–504.Google Scholar

WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67(6):601–11.Google Scholar

Nock, ML, Johnson, EM, Krugman, RR, et al. Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol 2011;31(2):112–17.Google Scholar

Watchko, JF. Hyperbilirubinemia in African American neonates: Clinical issues and current challenges. Semin Fetal Neonatal Med 2010;15(3):176–82.Google Scholar

Kaplan, M, Hammerman, C, Vreman, HJ, Stevenson, DK, Beutler, E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. J Pediatr 2001;139(1):137–40.Google Scholar

Herschel, M, Ryan, M, Gelbart, T, Kaplan, M. Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency. J Perinatol 2002;22(7):577–9.Google Scholar

Beutler, E, Baluda, MC. The separation of glucose-6-phosphate-dehydrogenase-deficient erythrocytes from the blood of heterozygotes for glucose-6-phosphate-dehydrogenase deficiency. Lancet 1964;1(7326):189–92.Google Scholar

Beutler, E, Blume, KG, Kaplan, JC, et al. International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol 1979;43(3):465–7.Google Scholar

Luzzatto, L. Glucose 6-phosphate dehydrogenase deficiency: From genotype to phenotype. Haematologica 2006;91(10):1303–6.Google Scholar

Beutler, E. G6PD deficiency. Blood 1994;84(11):3613–36.Google Scholar

Lin, Z, Fontaine, JM, Freer, DE, Naylor, EW. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 2005;86(1–2):212–19.Google Scholar

Kaplan, M, Hammerman, C. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: Biochemical versus genetic technologies. Semin Perinatol 2011;35(3):155–61.Google Scholar

Carpenter, KH, Wiley, V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta 2002;322(1–2):1–10.Google Scholar

Millington, DS, Sista, R, Eckhardt, A, et al. Digital microfluidics: A future technology in the newborn screening laboratory? Semin Perinatol 2010;34(2):163–9.Google Scholar

Heimall, J, Logan, BR, Cowan, MJ, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study. Blood 2017;130(25):2718–27.Google Scholar

Griffith, LM, Cowan, MJ, Kohn, DB, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: Current status and critical needs. J Allergy Clin Immunol 2008;122(6):1087–96.Google Scholar

Gaspar, HB, Qasim, W, Davies, EG, et al. How I treat severe combined immunodeficiency. Blood 2013;122(23):3749–58.Google Scholar

Dvorak, CC, Cowan, MJ. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant 2008;41(2):119–26.Google Scholar

Wahlstrom, JT, Dvorak, CC, Cowan, MJ. Hematopoietic stem cell transplantation for severe combined immunodeficiency. Curr Pediatr Rep 2015;3(1):1–10.Google Scholar

Malacarne, F, Benicchi, T, Notarangelo, LD, et al. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. Eur J Immunol 2005;35(11):3376–86.CrossRef Google Scholar PubMed

Gaspar, HB, Aiuti, A, Porta, F, et al. How I treat ADA deficiency. Blood 2009;114(17):3524–32.Google Scholar

Ferrua, F, Aiuti, A. Twenty-five years of gene therapy for ADA-SCID: From bubble babies to an approved drug. Hum Gene Ther 2017;28(11):972–81.Google Scholar

Cavazzana, M, Six, E, Lagresle-Peyrou, C, Andre-Schmutz, I, Hacein-Bey-Abina, S. Gene therapy for X-linked severe combined immunodeficiency: Where do we stand? Hum Gene Ther 2016;27(2):108–16.Google Scholar

Hacein-Bey-Abina, S, Pai, SY, Gaspar, HB, et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 2014;371(15):1407–17.Google Scholar

De Ravin, SS, Wu, X, Moir, S, et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med 2016;8(335):335ra57.Google Scholar

Mamcarz, E, Zhou, S, Lockey, T, et al. Lentiviral gene therapy with low dose busulfan for infants with SCID-X1 (revised). N Engl J Med 2019;380:1525–34.Google Scholar

Aiuti, A, Roncarolo, MG, Naldini, L. Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: Paving the road for the next generation of advanced therapy medicinal products. EMBO Mol Med 2017;9(6):737–40.Google Scholar

Punwani, D, Kawahara, M, Yu, J, et al. Lentivirus mediated correction of Artemis-deficient severe combined immunodeficiency. Hum Gene Ther 2017;28(1):112–24.Google Scholar

Atlas, SA. The sickle cell trait and surgical complications: A matched-pair patient analysis. JAMA 1974;229(8):1078–80.Google Scholar

Metras, D, Coulibaly, AO, Ouattara, K, et al. Open-heart surgery in sickle-cell haemoglobinopathies: Report of 15 cases. Thorax 1982;37(7):486–91.Google Scholar

Naik, RP, Haywood, C, Jr. Sickle cell trait diagnosis: Clinical and social implications. Hematol Am Soc Hematol Educ Prog 2015;2015:160–7.Google Scholar

Holtkamp, KCA, Mathijssen, IB, Lakeman, P, et al. Factors for successful implementation of population-based expanded carrier screening: Learning from existing initiatives. Eur J Public Health 2017;27(2):372–7.Google Scholar

Kaback, MM. Population-based genetic screening for reproductive counseling: The Tay–Sachs disease model. Eur J Pediatr 2000;159 Suppl 3:S192–5.Google Scholar

De Wert, GM, Dondorp, WJ, Knoppers, BM. Preconception care and genetic risk: Ethical issues. J Community Genet 2012;3(3):221–8.Google Scholar

Henneman, L, Borry, P, Chokoshvili, D, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet 2016;24(6):e1–e12.Google Scholar

Bombard, Y, Miller, FA, Hayeems, RZ, Avard, D, Knoppers, BM. Reconsidering reproductive benefit through newborn screening: A systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet 2010;18(7):751–60.Google Scholar

Mitchell, JJ, Capua, A, Clow, C, Scriver, CR. Twenty-year outcome analysis of genetic screening programs for Tay–Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 1996;59(4):793–8.Google Scholar

Lena-Russo, D, Badens, C, Aubinaud, M, et al. Outcome of a school screening programme for carriers of haemoglobin disease. J Med Screen 2002;9(2):67–9.Google Scholar

Amato, A, Cappabianca, MP, Lerone, M, et al. Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy. J Community Genet 2014;5(3):265–8.Google Scholar

van Elderen, T, Mutlu, D, Karstanje, J, et al. Turkish female immigrants’ intentions to participate in preconception carrier screening for hemoglobinopathies in the Netherlands: An empirical study. Public Health Genomics 2010;13(7–8):415–23.Google Scholar

Saffi, M, Howard, N. Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for beta-thalassaemia in the Middle East: A scoping review. Public Health Genomics 2015;18(4):193–203.Google Scholar

Kihlbom, U. Ethical issues in preconception genetic carrier screening. Ups J Med Sci 2016:1–4.Google Scholar

Langlois, S, Benn, P, Wilkins-Haug, L. Current controversies in prenatal diagnosis 4: Pre-conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenat Diagn 2015;35(1):23–8.Google Scholar

Nazareth, SB, Lazarin, GA, Goldberg, JD. Changing trends in carrier screening for genetic disease in the United States. Prenat Diagn 2015;35(10):931–5.Google Scholar

Lazarin, GA, Haque, IS. Expanded carrier screening: A review of early implementation and literature. Semin Perinatol 2016;40(1):29–34.Google Scholar

Ciske, DJ, Haavisto, A, Laxova, A, Rock, LZ, Farrell, PM. Genetic counseling and neonatal screening for cystic fibrosis: An assessment of the communication process. Pediatrics 2001;107(4):699–705.Google Scholar

Lewis, S, Curnow, L, Ross, M, Massie, J. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health 2006;42(9):533–7.Google Scholar

Hayeems, RZ, Bytautas, JP, Miller, FA. A systematic review of the effects of disclosing carrier results generated through newborn screening. J Genet Couns 2008;17(6):538–49.Google Scholar

Omran, AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971;49(4):509–38.Google Scholar

Darlison, MW, Modell, B. Sickle-cell disorders: Limits of descriptive epidemiology. Lancet 2013;381(9861):98–9.Google Scholar

Beutler, E, Waalen, J. The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration? Blood 2006;107:1747–50.Google Scholar

Henry, E, Christensen, RD. Reference intervals in neonatal hematology. Clin Perinatol 2015;42:483–97.Google Scholar

Wintrobe, MM. Blood of normal men and women. Bull John Hopkins Hosp 1933;53:118–40.Google Scholar

Jopling, J, Henry, E, Wiedmeier, SE, Christensen, RD. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: Data from a multihospital health care system. Pediatrics 2009;123:e333–7.Google Scholar

Ruíz-Argüelles, GJ, Sanchez-Medal, L, Loria, A, et al. Red cell indices in normal adults residing at altitude from sea level to 2670 meters. Am J Hematol 1980;8:265–71.Google Scholar

Oh, W, Lind, J. Venous and capillary hematocrit in newborn infants and placental transfusion. Acta Paediatr Scand 1966;55:38–42.Google Scholar

Linderkamp, O, Versmold, HT, Strohhacker, I, et al. Capillary–venous hematocrit differences in newborn infants. 1. Relationship to blood volume, peripheral blood flow, and acid-base parameters. Eur J Pediatr 1977:127;9–14.Google Scholar

Judkins, AJ, MacQueen, BC, Christensen, RD, et al. Automated quantification of fragmented red blood cells: Neonatal reference intervals and clinical disorders of neonatal intensive care unit patients with high values. Neonatology. 2018;115:5–12.Google Scholar

Christensen, RD, Lambert, DK, Richards, DS. Estimating the nucleated red blood cell ‘emergence time’ in neonates. J Perinatol 2014;34:116–19.Google Scholar

Christensen, RD, Albertine, KH, Dahl, MJ, et al. Nucleated red blood cell counts in term neonates following fetal hypoxia. Neonatology (in press).Google Scholar

Kim, YA, Makar, RS. Detection of fetomaternal hemorrhage. Am J Hematol 2012;87:417–23.Google Scholar

Badior, KE, Casey, JR. Molecular mechanism for the red blood cell senescence clock. IUBMB Life 2018;70:32–40.Google Scholar

Christensen, RD, Yaish, HM. Hemolytic disorders causing severe neonatal hyperbilirubinemia. Clin Perinatol 2015;42:515–27.Google Scholar

Christensen, RD, Lambert, DK, Henry, E, et al. End-tidal carbon monoxide as an indicator of the hemolytic rate. Blood Cells Mol Dis 2015;54:292–6.Google Scholar

Christensen, RD, Malleske, DT, Lambert, DK, Baer, VL, et al. Measuring end-tidal carbon monoxide of jaundiced neonates in the birth hospital to identify those with hemolysis. Neonatology 2016;109:1–5.Google Scholar

Bhutani, VK, Maisels, MJ, Schutzman, DL, Castillo Cuadrado, ME, et al. Identification of risk for neonatal haemolysis. Acta Paediatr 2018;107:1350–6.CrossRef Google Scholar PubMed

Tidmarsh, GF, Wong, RJ, Stevenson, DK. End-tidal carbon monoxide and hemolysis. J Perinatol 2014;34:577–81.Google Scholar

Christensen, RD, Yaish, HM, Lemons, RS. Neonatal hemolytic jaundice: Morphologic features of erythrocytes that will help you diagnose the underlying condition. Neonatology 2014;105:243–9.Google Scholar

MacQueen, BC, Christensen, RD, Ward, DM, et al. The iron status at birth of neonates with risk factors for developing iron deficiency: A pilot study. J Perinatol 2017;37:436–40.Google Scholar

MacQueen, BC, Robert, D. Christensen, RD, Baer, VL, Ward, DM, Snow, GL. Screening umbilical cord blood for congenital iron deficiency. Blood Cells Mol Dis 2019;77:95–100.Google Scholar

Yoon, D, Ponka, P, Prchal, JT. Hypoxia 5. Hypoxia and hematopoiesis. Am J Physiol Cell Physiol 2011;300:C1215–C1222.Google Scholar

Shih, HM, Wu, CJ, Lin, SL. Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc 2018;117:955–63.Google Scholar

Zanjani, ED, Ascensao, JL, McGlave, PB, Banisadre, M, Ash, RC. Studies in the liver to kidney switch of erythropoietin production. J Clin Invest 1981;67:1183–8.Google Scholar

Eckardt, K-U, Ratcliffe, PJ, Tan, CC, Bauer, C, Kurtz, A. Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J. Clin. Invest 1992;89:753–60.Google Scholar

Kling, PJ, Schmidt, RL, Roberts, RA, Widness, JA. Serum erythropoietin levels during infancy: Associations with erythropoiesis. J Pediatr 1996;128:791–6.Google Scholar

Stockman, JA, III, Garcia, JF, Oski, FA. The anemia of prematurity: Factors governing the erythropoietin response. N Engl J Med 1977;296:647–50.Google Scholar

Ohls, RK. Evaluation and treatment of anemia in the neonate. In Christensen, RD, ed. Hematologic Problems of the Neonate (Philadelphia, PA: WB Saunders, 2000). pp. 137–69.Google Scholar

Lundstrom, U, Siimes, MA. At what age does iron supplementation become necessary in low-birth weight infants? J Pediatr 1977;91:878–83.CrossRef Google Scholar PubMed

Ohls, RK. Erythropoietin to prevent and treat the anemia of prematurity. Curr Opin Pediatr 1999;11:108–14.Google Scholar

Maier, RF, Obladen, M, Messinger, D, Wardrop, CAJ. Factors related to transfusion in very low birthweight infants treated with erythropoietin. Arch Dis Child 1996;74:F182–F186.Google Scholar

Ohls, RK. Erythropoietin treatment in extremely low birth weight infants: Blood in versus blood out. J Pediatr 2002;141:3–6.Google Scholar

Kling, PJ, Sullivan, TM, Leftwich, ME, Roe, DJ. Score for neonatal acute physiology predicts erythrocyte transfusions in premature infants. Arch Dis Pediatr Adolesc Med 1997;151:27–31.Google Scholar

Ekhaguere, OA, Morriss, FH, Jr., Bell, EF, Prakash, N, Widness, JA. Predictive factors and practice trends in red blood cell transfusions for very-low-birth-weight infants. Pediatr Res 2016;79:736–41.Google Scholar

Shannon, KM, Keith, JM, Mentzer, WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1–10.Google Scholar

Widness, JA, Seward, VJ, Kromer, IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680–7.Google Scholar

Hume, H. Red blood cell transfusions for preterm infants: The role of evidence-based medicine. Sem Perinatol 1997;21:8–19.Google Scholar

Bednarek, FJ, Weisberger, S, Richardson, DK, et al. Variations in blood transfusions among newborn intensive care units. J Pediatr 1998;133:601–7.Google Scholar

Ringer, SA, Richardson, DK, Sacher, RA, Keszler, M, Churchill, WH. Variations in transfusion practice in neonatal intensive care. Pediatrics 1998;101:194–200.Google Scholar

Bell, EF, Strauss, RG, Widness, JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005;115:1685–91.Google Scholar

Luban, NL. Management of anemia in the newborn. Early Hum Dev 2008;84:493–8.Google Scholar

Becquet, O, Guyot, D, Kuo, P, et al. Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants. BMC Pediatr 2013;13:176.Google Scholar

Maier, RF, Sonntag, J, Walka, MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 2000;136:220–4.Google Scholar

Donato, H, Vain, N, Rendo, P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105:1066–1072.Google Scholar

Widness, JA, Kulhavy, JC, Johnson, KJ, et al. Clinical performance of an in-line point-of-care monitor in neonates. Pediatrics 2000;106:497–504.Google Scholar

Moya, MP, Clark, RH, Nicks, J, Tanaka, DT. The effects of bedside blood gas monitoring on blood loss and ventilator management. Biol Neonate 2001;80:257–61.Google Scholar

Lin, JC, Strauss, RG, Kulhavy, JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics.2000;106:e19.Google Scholar

Bishara, N, Ohls, RK. Current controversies in the management of the anemia of prematurity. Semin Perinatol 2009;33:29–34.Google Scholar

Kinmond, S, Aitchison, TC, Holland, BM, et al. Umbilical cord clamping and preterm infants: A randomised trial. Brit Med J 1993;306:172–5.Google Scholar

Wardrop, CAJ, Holland, BM. The roles and vital importance of placental blood to the newborn infant. J Perinat Med 1995;23:139–43.Google Scholar

Ibrahim, HM, Krouskop, RW, Lewis, DF, Dhanireddy, R. Placental transfusion: Umbilical cord clamping and preterm infants. J Perinatol.2000;20:351–4.Google Scholar

Rabe, H, Diaz-Rossello, JL, Duley, L, Dowswell, T. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012;8:CD003248.Google Scholar

Committee on Obstetric Practice. Committee opinion no. 684: Delayed umbilical cord clamping after birth. Obstet Gynecol 2017;129:e5–e10.Google Scholar

Strauss, RG. How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion 2008;48:209–17.Google Scholar

Aladangady, N, Aitchison, TC, Beckett, C, et al. Is it possible to predict the blood volume of a sick preterm infant? Arch Dis Child Fetal Neonatal Ed 2004;89:F344–7.Google Scholar

Backes, CH, Rivera, BK, Haque, U, et al. Placental transfusion strategies in very preterm neonates: A systematic review and meta-analysis. Obstet Gynecol 2014;124:47–56.Google Scholar

Hutton, EK, Hassan, ES. Late vs early clamping of the umbilical cord in full-term neonates: Systematic review and meta-analysis of controlled trials. JAMA 2007;297:1241–52.Google Scholar

Chaparro, CM, Neufeld, LM, Alvarez, GT, Cedillo, RE-L, Dewey, KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: A randomised controlled trial. Lancet 2006;367:1997–2004.Google Scholar

Ohls, RK, Ehrenkranz, RA, Wright, LL, et al. The effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birthweight: A multicenter, randomized controlled trial. Pediatrics 2001;108:934–42.Google Scholar

Roseff, SD, Luban, NL, Manno, CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002;42:1398–413.Google Scholar

Strauss, RG. Practical issues in neonatal transfusion practice. Am J Clin Path 1997;107:S57–S63.Google Scholar

Simon, TL, Alverson, DC, AuBuchon, J, et al. Practice parameter for the use of red blood cell transfusions. Arch Pathol Lab Med 1998;122:130–8.Google Scholar

Kirpalani, H, Whyte, RK, Andersen, C, et al. The Premature Infants in Need of Transfusion (PINT) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301–7.Google Scholar

Whyte, R, Kirpalani, H. Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev 2011;11:CD000512.Google Scholar

Ibrahim, M, Ho, SK, Yeo, CL. Restrictive versus liberal red blood cell transfusion thresholds in very low birth weight infants: A systematic review and meta-analysis. J Paediatr Child Health 2014;50:122–30.Google Scholar

McCoy, TE, Conrad, AL, Richman, LC, et al. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011;17:347–67.Google Scholar

McCoy, TE, Conrad, AL, Richman, LC, et al. The relationship between brain structure and cognition in transfused preterm children at school age. Dev Neuropsychol 2014;39:226–32.Google Scholar

Whyte, RK, Kirpalani, H, Asztalos, EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009;123:207–13.Google Scholar

Warwood, TL, Ohls, RK, Lambert, DK, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006;26:296–300.Google Scholar

Vamvakas, EC, Strauss, RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406–15.Google Scholar

Ohlsson, A, Aher, SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev 2017;11:CD004863.Google Scholar

Aher, SM, Ohlsson, A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2014;4:CD004868.Google Scholar

Aher, SM, Ohlsson, A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012;10:CD004865.Google Scholar

Maier, RF, Obladen, M, Kattner, E, et al. High- versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998;132:866–70.Google Scholar

Carnielli, VP, D Riol, R, Montini, G. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Arch Dis Child 1998;79:F44–F48.Google Scholar

Brown, MS, Jones, MA, Ohls, RK, Christensen, RD. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. J Pediatr 1993;122:655–7.Google Scholar

Widness, JA, Veng-Pedersen, P, Peters, C, et al. Erythropoietin pharmacokinetics in premature infants: Developmental, non-linearity, and treatment effects. J Appl Physiol 1996;80:140–8.Google Scholar

Ohls, RK, Veerman, MW, Christensen, RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr 1996;128:518–23.Google Scholar

Brown, MS, Keith, JF. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: A randomized trial. Pediatrics 1999;104:210–15.Google Scholar

Bechensteen, AG, Håga, P, Halvorsen, S, et al. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Arch Dis Child 1993;69:19–23.Google Scholar

Messer, J, Haddad, J, Donato, L, Astruc, D, Matis, J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519–23.Google Scholar

Bechensteen, AG, Halvorsen, S, Haga, P, PM C, Liestøl, K. Erythropoietin (EPO), protein and iron supplementation and the prevention of anaemia of prematurity: Effects on serum immunoreactive Epo, growth and protein and iron metabolism. Acta Paediatr 1996;85:490–5.Google Scholar

Worthington-White, D, Behnke, M, Gross, S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr 1994;60:930–5.Google Scholar

Haiden, N, Schwindt, J, Cardona, F, et al. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics 2006;118:2004–13.Google Scholar

Carnielli, VP, Montini, G, Da Riol, R, Dall’Amico, R, Cantarutti, F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98–102.Google Scholar

Meyer, MP, Haworth, C, Meyer, JH, Commerford, A. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996;129:258–63.Google Scholar

Kivivuori, SM, Virtanen, M, Raivio, KO, Viinikka, L, Siimes, MA. Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants. Eur J Pediatr 1999;158:147–51.Google Scholar

Pollak, A, Hayde, M, Hayn, M, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 2001;107:78–85.Google Scholar

Ohls, RK, Harcum, J, Schibler, KR, Christensen, RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study. J Pediatr 1997;131:661–5.Google Scholar

Kumar, P, Shankaran, S, Krishnan, RG. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: A randomized, double-blind, placebo-controlled trial. J Perinatol 1998;18:173–7.Google Scholar

Ohls, RK, Ehrenkranz, RA, Lemons, JA, et al. A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants. Pediatr Res 1999;45:216A.Google Scholar

Zipursky, A. The risk of hematopoietic growth factor therapy in newborn infants. Pediatr Res 2002;51:549.Google Scholar

Ohls, RK, Christensen, RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991;119:781–8.Google Scholar

Beck, D, Masserey, E, Meyer, M, Calame, A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr 1991;150:767–72.Google Scholar

Halperin, DS, Wacker, P, Lacourt, G, et al. Effects of recombinant human erythropoietin in infants with anemia of prematurity: A pilot study. J Pediatr 1990;116:779–86.Google Scholar

Emmerson, A. Double blind trial of recombinant human erythropoietin in preterm infants: Comment. Archives Dis Child 1993;69:542.Google Scholar

Brown, MS, Baron, AE, France, EK, Hamman, RF. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS 2006;10:143–9.Google Scholar

Ashley, RA, Dubuque, SH, Dvorak, B, et al. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 2002;51:472–8.Google Scholar

Rao, R, Georgieff, MK. Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med 2007;12:54–63.Google Scholar

Ledbetter, DJ, Juul, SE. Erthropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 2000;35:178–82.Google Scholar

Ohls, RK, Osborne, KA, Chrstensen, RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trial. J Pediatr 1995;126:421–6.Google Scholar

Bierer, R, Peceny, MC, Hartenberger, CH, Ohls, RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics. 2006;118:e635-640.Google Scholar

Ohls, RK, Cannon, DC, Phillips, J, et al. Preschool assessment of preterm infants treated with darbepoetin and erythropoietin. Pediatrics 2016;137:e20153859.Google Scholar

Neubauer, AP, Voss, W, Wachtendorf, M, Jungmann, T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010;67:657–66.Google Scholar

Massaro, AN, Wu, YW, Bammler, TK, et al. Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 2018;194:67–75.Google Scholar

Juul, SE, Comstock, BA, Heagerty, PJ, et al. High-dose erythropoietin for asphyxia and encephalopathy (HEAL): A randomized controlled trial – background, aims, and study protocol. Neonatology 2018;113:331–8.Google Scholar

Garg, B, Sharma, D, Bansal, A. Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: Presently where do we stand. J Matern Fetal Neonatal Med 2018;31:3214–24.Google Scholar

Fischer, HS, Reibel, NJ, Buhrer, C, Dame, C. Prophylactic early erythropoietin for neuroprotection in preterm infants: A meta-analysis. Pediatrics 2017;139:e20164317.Google Scholar

Juul, SE, Mayock, DE, Comstock, BA, Heagerty, PJ. Neuroprotective potential of erythropoietin in neonates; design of a randomized trial. Matern Health Neonatol Perinatol 2015;1:27.Google Scholar

Fauchere, JC, Koller, BM, Tschopp, A, et al. Swiss erythropoietin neuroprotection trial g. safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr 2015;167:52–7 e53.Google Scholar

Natalucci, G, Latal, B, Koller, B, et al. Swiss EPONTG. Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: A randomized clinical trial. JAMA 2016;315:2079–85.Google Scholar

Shireman, TI, Hilsenrath, PE, Strauss, RG, Widness, JA, Mutnick, AH. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. Arch Pediatr Adolesc Med 1994;148:582–8.Google Scholar

Maier, RF, Obladen, M, Scigalla, P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173–8.Google Scholar

Fain, J, Hilsenrath, P, Widness, JA, Strauss, RG, Mutnick, AH. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity. Transfusion 1995;35:936–43.Google Scholar

Yeo, CL, Choo, S, Ho, LY. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health 2001;37:352–8.Google Scholar

Atasay, B, Gunlemez, A, Akar, N, Arsan, S. Does early erythropoietin therapy decrease transfusions in anemia of prematurity. Indian J Pediatr 2002;69:389–91.Google Scholar

Avent, M, Cory, BJ, Galpin, J, et al. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country. J Tropical Pediatr 2002;48:227–33.Google Scholar

Oski, FA. Iron deficiency in infancy and childhood. New Engl J Med 1993;329:190–3.Google Scholar

Oski, FA. Differential diagnosis of anemia. In Nathan, DG, Oski, FA, eds. 4th ed. Hematology of Infancy and Childhood (Philadelphia, PA: W.B. Saunders, 1993). pp. 346–53.Google Scholar

Dallman, PR. Iron deficiency in the weanling: A nutritional problem on the way to resolution. Acta Paediatr Scand Suppl 1986;323:59–67.Google Scholar

Harthoorn-Lasthuizen, EJ, Lindemans, J, Langenhuijsen, MM. Does iron-deficient erythropoiesis in pregnancy influence fetal iron supply? Acta Obstet Gynecol Scand 2001;80:392–6.Google Scholar

McCarthy, PJ, Zundel, HR, Johnson, KR, Blohowiak, SE, Kling, PJ. Impact of growth restriction and other prenatal risk factors on cord blood iron status in prematurity. J Pediatr Hematol Oncol 2016;38(3):210–15.Google Scholar

Mukhopadhyay, K, Yadav, RK, Kishore, SS, et al. Iron status at birth and at 4 weeks in preterm-SGA infants in comparison with preterm and term-AGA infants. J Matern Fetal Neonatal Med 2012;25:1474–8.Google Scholar

McLimore, HM, Phillips, AK, Blohowiak, SE, et al. Impact of multiple prenatal risk factors on newborn iron status at delivery. J Pediatr Hematol Oncol 2013;35:473–77.Google Scholar

Jones, AD, Zhao, G, Jiang, YP, et al. Maternal obesity during pregnancy is negatively associated with maternal and neonatal iron status. Eur J Clin Nutr 2016;70(8):918–24.Google Scholar

MacQueen, BC, Christensen, RD, Ward, DM, et al. The iron status at birth of neonates with risk factors for developing iron deficiency: A pilot study. J Perinatol 2017;37:436–40.Google Scholar

McCarthy, EK, Kenny, LC, Hourihane, JOB, et al. Impact of maternal, antenatal and birth-associated factors on iron stores at birth: Data from a prospective maternal-infant birth cohort. Eur J Clin Nutr 2017;71:782–7.Google Scholar

Fomon, SJ. Iron. In Fomon, S, ed. Nutrition of Normal Infants (St. Louis, MO: Mosby, 1993). pp. 239–60.Google Scholar

Ehrenkranz, RA. Iron requirements of preterm infants. Nutrition 1994;10:77–8.Google Scholar

Fomon, SJ, Ziegler, EE, Nelson, SE, Serfass, RE, Frantz, JA. Erythrocyte incorporation of iron by 56-day-old infants fed a 58Fe-labeled supplement. Pediatr Res 1995;38:373–8.Google Scholar

Widness, JA, Lombard, KA, Ziegler, EE, et al. Erythroctye incorporation and absorption of 58Fe in premature infants treated with erythropoietin. Pediatr Res 1997;41:416–23.Google Scholar

Georgieff, MK. Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev 2011;69 Suppl 1:S43–48.Google Scholar

Saarinen, UM, Siimes, MA. Serum ferritin in assessment of iron nutrition in healthy infants. Acta Paediatr Scand 1978;67:745–51.Google Scholar

Al-Kharfy, T, Smyth, JA, Wadsworth, L, et al. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996;129:89–96.Google Scholar

Bader, D, Blondheim, O, Jonas, R, et al. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity. Acta Paediatr 1996;85:496–501.Google Scholar

Bechensteen, AG, Halvorsen, S, Haga, P, Cotes, PM, Liestol, K. Erythropoietin, protein and iron supplementation and the prevention of anaemia of prematurity: Effects on serum immunoreactive Epo, growth and protein and iron metabolism. Acta Paediatr. 1996;85:490–5.Google Scholar

Emmerson, A. Role of erythropoietin in the newborn. Archives Dis Child 1993;69:273–5.Google Scholar

Meyer, MP, Meyer, JH, Commerford, A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918–23.Google Scholar

Morris, KP, Watson, S, Reid, MM, Hamilton, PJ, Coulthard, MG. Assessing iron status in children with chronic renal failure on erythropoietin: Which measurements should we use? Pediatr Nephrol 1994;8:51–6.Google Scholar

Goodnough, LT, Skikne, B, Brugnara, C. Erythropoietin, iron and erythropoiesis. Blood 2000;96:823–33.Google Scholar

Akkermans, MD, Uijterschout, L, Abbink, M, et al. Predictive factors of iron depletion in late preterm infants at the postnatal age of 6 weeks. Eur J Clin Nutr 2016;70:941–6.Google Scholar

Taetle, R. The role of transferrin receptors in hemopoietic cell growth. Exp Hematol 1990;18:360–5.Google Scholar

Kivivuori, SM, Heikinheimo, M, Teppo, A-M, Siimes, MA. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants Pediatr Res. 1994;36:85–9.Google Scholar

Bechensteen, AG, Haga, P, Halvorsen, S, et al. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake. Eur J Pediatr 1997;156:56–61.Google Scholar

Kohgo, Y, Niitsu, Y, Kondo, H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987;70:1955–8.Google Scholar

Beguin, Y, Clemons, GK, Pootrakul, P, Fillet, G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067–76.Google Scholar

Beguin, Y, Loo, M, S. RZ, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993;82:2010–16.Google Scholar

Rusia, U, Flowers, C, Madan, N, Agarwal, N, Sood, SK. Serum transferrin receptor levels in the evaluation of iron deficiency in the neonate. Acta Paediatr Japon 1995;38:455–9.Google Scholar

Kling, PJ, Widness, JA. Transfusions, (RBC Tx) and erythropoiesis indicators influence serum transferrin receptors (TfR) levels in premature infants. Pediatr Res 1995;37:282A.Google Scholar

Kling, PJ, Roberts, RA, Widness, JA. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants. Am J Pediatr Hem/Onc 1997;20:309–14.Google Scholar

Krallis, N, Cholevas, V, Mavridis, A, et al. Effect of recombinant human erythropoietin in preterm infants. Eur J Haematol 1999;63:71–6.Google Scholar

Kasper, DC, Widness, JA, Haiden, N, Berger, A, et al. Characterization and differentiation of iron status in anemic very low birth weight infants using a diagnostic nomogram. Neonatology 2009;95:164–71.Google Scholar

Braun, J, Lindner, K, Schreiber, M, Heidler, RA, Horl, WH. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. Nephrol Dial Transplan 1997;12:1173–81.Google Scholar

Rettmer, RL, Carlson, TH, Origenes, ML, Jack, RM, Labbe, RF. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 1999;104:e37.Google Scholar

Kaltwasser, JP, Gottschalk, R. Erythropoietin and iron. Kidney Int 1999;55:S49–S56.Google Scholar

National Kidney Foundation. Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure (New York: National Kidney Foundation; 1999), available online at https://bit.ly/33S1B23.Google Scholar

Lott, DG, Zimmerman, MB, Labbe’, RF, Kling, PJ, Widness, JA. Erythrocyte zinc protoporphyrin ratios are elevated with prematurity and with fetal hypoxia. Pediatrics 2005;116:414–22.Google Scholar

Miller, SM, McPherson, RJ, Juul, SE. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr 2006;148:44–8.Google Scholar

Winzerling, JJ, Kling, PJ. Iron deficient erythropoiesis in premature infants measured by blood zinc protoporphyrin/heme. J Pediatr 2001;139:134–6.Google Scholar

Blohowiak, SE, Chen, ME, Repyak, KS, et al. Reticulocyte enrichment of zinc protoporphyrin/heme discriminates impaired iron supply during early development. Pediatr Res 2008;64:63–7.Google Scholar

Shaw, JCL. Iron absorption by the premature infant: The effect of transfusion and iron supplements on the serum ferritin levels. Acta Paediatr Scand Suppl 1982;299:83–9.Google Scholar

Arad, I, Konijn, AM, Linder, N, Goldstein, MDM, Kaufmann, NA. Serum ferritin levels in preterm infants after multiple blood transfusions. Am J Perinatol 1988;5:40–3.Google Scholar

Brown, MS. Effect of transfusion and phlebotomy on serum ferritin levels in low birth weight infants. J Perinatol 1996;16:39–42.Google Scholar

Soubasi, V, Kremenopoulos, G, Diamanti, E, et al. Follow-up of very low birth weight infants after erythrpoietin treatment to prevent anemia of prematurity. J Pediatr 1995;127:291–7.Google Scholar

Sullivan, JL. Iron, plasma antioxidants and the ‘oxygen radical disease of prematurity’. Am J Dis Child 1988;142:1341–4.Google Scholar

Evans, PJ, Evans, R, Kovar, IZ, Holton, AF, Halliwell, B. Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Letters 1992;303:210–12.Google Scholar

Miller, NJ, Rice-Evans, C, Davies, MJ, Gopinathan, V, Milner, A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407–12.Google Scholar

Humphrey, MJ, Harrell-Bean, HA, Eskelson, C, Corrigan, JJ. Blood transfusion in the neonate: Effects of dilution and age of blood on hemolysis. J Pediatr 1982;101:605–7.Google Scholar

Kling, PJ, Reichard, RD, Roberts, RA, Winzerling, JJ, Woodward, SS. The effects of transfusions on oxidative stress and plasma erythropoietin levels in premature infants. Ann Hematol 2000;79:B13.Google Scholar

Obladen, M, Maier, R, Grauel, L, et al. Recombinant human erythropoietin (rhEPO) for prevention of anaemia of prematurity: A randomized multicentre trial. Pediatr Res 1990;28:287A(Abstr).Google Scholar

Shannon, KM, Mentzer, WC, Abels, RI, et al. Recombinant human erythropoietin in anemia of prematurity: Preliminary results of a double-blind placebo controlled pilot study. J Pediatr 1991;118:949–55.Google Scholar

Shannon, KM, Mentzer, WC, Abels, RI, et al. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot study. J Pediatr 1992;120:586–92.Google Scholar

Soubasi, V, Kremenpoulos, G, Diamandi, E, Tsantali, C, Tsakiris, D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993;34:675–9.Google Scholar

Ronnestad, A, Moe, PJ, Breivik, N. Enhancement of erythropoiesis by erythropoietin, bovine protein and energy fortified mother’s milk during anaemia of prematurity. Acta Paediatrica 1995;84:809–11.Google Scholar

Samanci, N, Ovali, F, Dagoglu, T. Effects of recombinant human erythropoietin in infants with very low birth weights. J Int Med Res 1996;24:190–8.Google Scholar

Giannakopoulou, C, Bolonaki, I, Stiakaki, E, et al. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia. Pediatr Hematol Oncol 1998;15:37–43.Google Scholar

Maier, RF, Obladen, M, Mueller-Hansen, I, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8–15.Google Scholar

Diamond, LK, Blackfan, KD, Baty, JM. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatr 1932;1:269–309.Google Scholar

Landsteiner, K, Weiner, A. An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Pro Soc Exp Biol Med 1940;43:223.Google Scholar

Mollison, PL. Methods of determining the posttransfusion survival of stored red cells. Transfusion 1984;24:93–6.Google Scholar

Bowman, JM. Treatment options for the fetus with alloimmune hemolytic disease. Transfus Med Rev 1990;4:191–207.Google Scholar

Chavez, GF, Mulinare, J, Edmonds, LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991;265:3270–4.Google Scholar

Murphy, SL. Deaths: Final data for 1998. Natl Vital Stat Rep 2000;48:1–105.Google Scholar

Liumbruno, GM, D’Alessandro, A, Rea, F, et al. The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus 2010;8:8–16.Google Scholar

Moise, KJ, Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75–81.Google Scholar

Bowman, JM, Pollock, JM, Penston, LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117–21.Google Scholar

Cohen, F, Zuelzer, WW. Mechanisms of isoimmunization. II. Transplacental passage and postnatal survival of fetal erythrocytes in heterospecific pregnancies. Blood 1967;30:796–804.Google Scholar

Huchet, J, Defossez, Y, Brossard, Y. Detection of transplacental hemorrhage during the last trimester of pregnancy. Transfusion 1988;28:506.Google Scholar

Feldman, N, Skoll, A, Sibai, B. The incidence of significant fetomaternal hemorrhage in patients undergoing cesarean section. Am J Obstet Gynecol 1990;163:855–8.Google Scholar

McKenna, DS, Nagaraja, HN, O’Shaughnessy, R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999;93:667–73.Google Scholar

Howard, H, Martlew, V, McFadyen, I, et al. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 1998;78:F62–6.Google Scholar

Clarke, CA. Preventing rhesus babies: The Liverpool research and follow up. Arch Dis Child 1989;64:1734–40.Google Scholar

Doyle, B, Quigley, J, Allen, C, Fitzgerald, J. Homozygous expression of fetal red cell antigen in donor oocyte pregnancy complicated by allo-immunisation: Are current antibody thresholds to trigger increased monitoring relevant? Transfus Med 2014;24:182–3.Google Scholar

Alsaati, G, Sandler, SG. Assisted reproductive technology: An uncommon, but increasing, cause of parent–child ABO discrepancy. Transfusion 2015;55:2048–9.Google Scholar

Simister, NE, Story, CM. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J Reprod Immunol 1997;37:1–23.Google Scholar

Palfi, M, Selbing, A. Placental transport of maternal immunoglobulin G. Am J Reprod Immunol. 1998;39:24–6.Google Scholar

Devey, ME, Voak, D. A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers. Immunology 1974;27:1073–9.Google Scholar

Palfi, M, Hilden, JO, Gottvall, T, Selbing, A. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn. Am J Reprod Immunol 1998;39:323–8.Google Scholar

Yamamoto, F, Clausen, H, White, T, Marken, J, Hakomori, S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229–33.Google Scholar

Ozolek, JA, Watchko, JF, Mimouni, F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatr 1994;125:87–91.Google Scholar

Maisels, MJ, Stevenson, DK, Watchko, JF. Care of the Jaundiced Neonate (New York: McGraw Hill, 2012).Google Scholar

Kaplan, M, Hammerman, C, Vreman, HJ, Wong, RJ, Stevenson, DK. Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates. J Pediatr 2010;157:772–7.Google Scholar

Naiman, JL. Erythroblastosis Fetalis (Philadelphia: W.B. Saunders, 1982).Google Scholar

Adewuyi, JO, Gwanzura, C, Mvere, D. Characteristics of anti-A and anti-B in black Zimbabweans. Vox Sang 1994;67:307–9.Google Scholar

Adewuyi, JO, Gwanzura, C. Racial difference between white and black Zimbabweans in the haemolytic activity of A, B, O antibodies. Afr J Med Med Sci 2001;30:71–4.Google Scholar

Murray, NA, Roberts, IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007;92:F83-88.Google Scholar

Watchko, JF. Common hematologic problems in the newborn nursery. Pediatr Clin North Am 2015;62:509–24.Google Scholar

Maisels, MJ, Watchko, JF. Routine blood typing and DAT in infants of group O mothers. J Perinatol 2013;33:579.Google Scholar

Judd, WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445–52.Google Scholar

AAP Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.Google Scholar

Avent, ND, Reid, ME. The Rh blood group system: A review. Blood. 2000;95:375–87.Google Scholar

Westhoff, CM. The Rh blood group system in review: A new face for the next decade. Transfusion 2004;44:1663–73.Google Scholar

Avent, ND. New insight into the Rh system: Structure and function. ISBT Science Series 2007;2:35–43.Google Scholar

Colin, Y, Cherif-Zahar, B, Le Van Kim, C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747–52.Google Scholar

Avent, ND, Martin, PG, Armstrong-Fisher, SS, et al. Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood 1997;89:2568–77.Google Scholar

Daniels, G, Green, C, Smart, E. Differences between RhD-negative Africans and RhD-negative Europeans. Lancet 1997;350:862–3.Google Scholar

Okuda, H, Kawano, M, Iwamoto, S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997;100:373–9.Google Scholar

Singleton, BK, Green, CA, Avent, ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12–18.Google Scholar

Sun, CF, Chou, CS, Lai, NC, Wang, WT. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang 1998;75:52–7.Google Scholar

Winters, JL, Pineda, AA, Gorden, LD, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413–20.Google Scholar

Jakobowicz, R, Williams, L, Silberman, F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972;23:376–81.Google Scholar

Bowman, JM, Chown, B, Lewis, M, Pollock, JM. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J 1978;118:623–7.Google Scholar

Tovey, LA, Townley, A, Stevenson, BJ, Taverner, J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet 1983;2:244–6.Google Scholar

Nevanlinna, HR, Anttinen, EE, Vainio, T. Hemolytic disease of newborn due to Rh isoimmunization: Considerations on therapy and prognosis. Duodecim 1956;72:354–69.Google Scholar

Clarke, C, Finn, R, McConnell, R, Sheppard, P. The protection afforded by ABO incompatibility against erythroblastosis due to rhesus anti-D. Int Arch Allergy Immunol 1958;13:377–81.Google Scholar

Ascari, WQ, Levine, P, Pollack, W. Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies. Br Med J 1969;1:399–401.Google Scholar

Murray, S, Knox, EG, Walker, W. Rhesus haemolytic disease of the newborn and the ABO groups. Vox Sang 1965;10:6–31.Google Scholar

Bollason, G, Hjartardottir, H, Jonsson, T, et al. Red blood cell alloimmunization in pregnancy during the years 1996–2015 in Iceland: A nationwide population study. Transfusion 2017;57:2578–85.Google Scholar

Awowole, I, Cohen, K, Rock, J, Sparey, C. Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England. Eur J Obstet Gynecol Reprod Biol 2019;237:89–92.Google Scholar

Moran, P, Robson, SC, Reid, MM. Anti-E in pregnancy. BJOG 2000;107:1436–8.Google Scholar

McAdams, RM, Dotzler, SA, Winter, LW, Kerecman, JD. Severe hemolytic disease of the newborn from anti-e. J Perinatol 2008;28:230–2.Google Scholar

Sturgeon, P. Hematological observations on the anemia associated with blood type Rhnull. Blood 1970;36:310–20.Google Scholar

Bowell, PJ, Allen, DL, Entwistle, CC. Blood group antibody screening tests during pregnancy. Br J Obstet Gynaecol 1986;93:1038–43.Google Scholar

Filbey, D, Hanson, U, Wesstrom, G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: A 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995;74:687–92.Google Scholar

Kozlowski, CL, Lee, D, Shwe, KH, Love, EM. Quantification of anti-c in haemolytic disease of the newborn. Transfus Med 1995;5:37–42.Google Scholar

Wenk, RE, Goldstein, P, Felix, JK. Alloimmunization by hr’(c), hemolytic disease of newborns, and perinatal management. Obstet Gynecol 1986;67:623–6.Google Scholar

Bowell, PJ, Brown, SE, Dike, AE, Inskip, MJ. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 1986;93:1044–8.Google Scholar

Babinszki, A, Berkowitz, RL. Haemolytic disease of the newborn caused by anti-c, anti-E and anti-Fya antibodies: Report of five cases. Prenat Diagn 1999;19:533–6.Google Scholar

Mouro, I, Colin, Y, Cherif-Zahar, B, Cartron, JP, Le Van Kim, C. Molecular genetic basis of the human Rhesus blood group system. Nat Genet 1993;5:62–5.Google Scholar

Moncharmont, P, Juron-Dupraz, F, Rigal, D, Vignal, M, Meyer, F. Haemolytic disease of two newborns in a Rhesus anti-e alloimmunized woman. Review of literature.Haematologia (Budap) 1990;23:97–100.Google Scholar

Coombs, RR, Mourant, AE, Race, RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol 1945;26:255–66.Google Scholar

Bowman, JM, Pollock, JM, Manning, FA, Harman, CR, Menticoglou, S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239–44.Google Scholar

Babinszki, A, Lapinski, RH, Berkowitz, RL. Prognostic factors and management in pregnancies complicated with severe Kell alloimmunization: Experiences of the last 13 years. Am J Perinatol 1998;15:695–701.Google Scholar

Southcott, MJ, Tanner, MJ, Anstee, DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 1999;93:4425–35.Google Scholar

Weiner, CP, Widness, JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996;174:547–51.Google Scholar

Vaughan, JI, Manning, M, Warwick, RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798–803.Google Scholar

Vaughan, JI, Warwick, R, Letsky, E, et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247–52.Google Scholar

Mayne, KM, Bowell, PJ, Pratt, GA. The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol 1990;12:379–85.Google Scholar

Redman, CM, Marsh, WL. The Kell blood group system and the McLeod phenotype. Semin Hematol 1993;30:209–18.Google Scholar

Gorlin, JB, Kelly, L. Alloimmunisation via previous transfusion places female Kpb-negative recipients at risk for having children with clinically significant hemolytic disease of the newborn. Vox Sang 1994;66:46–8.Google Scholar

Lowe, RF, Musengezi, AT, Moores, P. Severe hemolytic disease of the newborn associated with anti-JSb. Transfusion 1978;18:466–8.Google Scholar

Gordon, MC, Kennedy, MS, O’Shaughnessy, RW, Waheed, A. Severe hemolytic disease of the newborn due to anti-Js(b). Vox Sang 1995;69:140–1.Google Scholar

Miller, LH, Mason, SJ, Clyde, DF, McGinniss, MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy.N Engl J Med 1976;295:302–4.Google Scholar

Hadley, TJ, Peiper, SC. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077–91.Google Scholar

Horuk, R, Chitnis, CE, Darbonne, WC, et al. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 1993;261:1182–4.Google Scholar

Sim, BK, Chitnis, CE, Wasniowska, K, Hadley, TJ, Miller, LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994;264:1941–4.Google Scholar

Tournamille, C, Le Van Kim, C, Gane, P, Cartron, JP, Colin, Y. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995;95:407–10.Google Scholar

Tournamille, C, Colin, Y, Cartron, JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224–8.Google Scholar

Chaudhuri, A, Polyakova, J, Zbrzezna, V, Pogo, AO. The coding sequence of Duffy blood group gene in humans and simians: Restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995;85:615–21.Google Scholar

Weatherall, DJ. Host genetics and infectious disease. Parasitology 1996;112 Suppl:S23–29.Google Scholar

Peiper, SC, Wang, ZX, Neote, K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311–17.Google Scholar

Sosler, SD, Perkins, JT, Fong, K, Saporito, C. The prevalence of immunization to Duffy antigens in a population of known racial distribution. Transfusion 1989;29:505–7.Google Scholar

Vescio, LA, Farina, D, Rogido, M, Sola, A. Hemolytic disease of the newborn caused by anti-Fyb. Transfusion 1987;27:366.Google Scholar

Shah, VP, Gilja, BK. Hemolytic disease of newborn due to anti-Duffy (Fya). NY State J Med 1983;83:244–5.Google Scholar

Weinstein, L, Taylor, ES. Hemolytic disease of the neonate secondary to anti-Fya. Am J Obstet Gynecol 1975;121:643–5.Google Scholar

Goodrick, MJ, Hadley, AG, Poole, G. Haemolytic disease of the fetus and newborn due to anti-Fy(a) and the potential clinical value of Duffy genotyping in pregnancies at risk. Transfus Med 1997;7:301–4.Google Scholar

Mallinson, G, Soo, KS, Schall, TJ, Pisacka, M, Anstee, DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: The molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823–9.Google Scholar

Buchanan, DI, Sinclair, M, Sanger, R, Gavin, J, Teesdale, P. An Alberta Cree Indian with a rare Duffy antibody, anti-Fy 3. Vox Sang 1976;30:114–21.Google Scholar

Lawicki, S, Covin, RB, Powers, AA. The Kidd (JK) Blood Group System. Transfus Med Rev 2017;31:165–72.Google Scholar

Olives, B, Merriman, M, Bailly, P, et al. The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet 1997;6:1017–20.Google Scholar

Woodfield, DG, Douglas, R, Smith, J, Simpson, A, Pinder, L, Staveley, JM. The Jk(a-b-) phenotype in New Zealand Polynesians. Transfusion 1982;22:276–8.Google Scholar

Dorner, I, Moore, JA, Chaplin, H, Jr. Combined maternal erythrocyte autosensitization and materno-fetal Jk incompatibility. Transfusion 1974;14:212–19.Google Scholar

Merlob, P, Litwin, A, Reisner, SH, Cohen, IJ, Zaizov, R. Hemolytic disease of the newborn caused by anti-Jkb. Pediatr Hematol Oncol 1987;4:357–60.Google Scholar

Thakral, B, Malhotra, S, Saluja, K, Kumar, P, Marwaha, N. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy. Transfus Apher Sci 2010;43:41–3.Google Scholar

Pierce, SR, Hardman, JT, Steele, S, Beck, ML. Hemolytic disease of the newborn associated with anti-Jk3. Transfusion 1980;20:189–91.Google Scholar

Bruce, LJ, Pan, RJ, Cope, DL, et al. Altered structure and anion transport properties of band 3 (AE1, SLC4A1) in human red cells lacking glycophorin A. J Biol Chem 2004;279:2414–40.Google Scholar

Tomita, M, Furthmayr, H, Marchesi, VT. Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence. Biochemistry 1978;17:4756–70.Google Scholar

Geifman-Holtzman, O, Wojtowycz, M, Kosmas, E, Artal, R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272–5.Google Scholar

Pal, M, Williams, B. Prevalence of maternal red cell alloimmunisation: A population study from Queensland, Australia. Pathology 2015;47:151–5.Google Scholar

Yasuda, H, Ohto, H, Nollet, KE, et al. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: A case report and review of the Japanese literature. Transfus Med Rev 2014;28:1–6.Google Scholar

De Young-Owens, A, Kennedy, M, Rose, RL, Boyle, J, O’Shaughnessy, R. Anti-M isoimmunization: Management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 1997;90:962–6.Google Scholar

Duguid, JK, Bromilow, IM, Entwistle, GD, Wilkinson, R. Haemolytic disease of the newborn due to anti-M. Vox Sang 1995;68:195–6.Google Scholar

Mayne, KM, Bowell, PJ, Green, SJ, Entwistle, CC. The significance of anti-S sensitization in pregnancy. Clin Lab Haematol 1990;12:105–7.Google Scholar

Smith, G, Knott, P, Rissik, J, de la Fuente, J, Win, N. Anti-U and haemolytic disease of the fetus and newborn. Br J Obstet Gynaecol 1998;105:1318–21.Google Scholar

Novaretti, MC, Jens, E, Pagliarini, T, et al. Hemolytic disease of the newborn due to anti-U.Rev Hosp Clin Fac Med Sao Paulo 2003;58:320–3.Google Scholar

Zipursky, A, Paul, VK. The global burden of Rh disease. Arch Dis Child Fetal Neonatal Ed 2011;96:F84–85.Google Scholar

Clarke, CA, Mollison, PL. Deaths from Rh haemolytic disease of the fetus and newborn, 1977–87. J R Coll Physicians Lond 1989;23:181–4.Google Scholar

McMaster Conference on Prevention of Rh Immunization 28–30 September, 1977. Vox Sang 1979;36:50–64.Google Scholar

Joseph, KS, Kramer, MS. The decline in Rh hemolytic disease: Should Rh prophylaxis get all the credit? Am J Public Health 1998;88:209–15.Google Scholar

Trolle, B. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand 1989;68:45–7.Google Scholar

Queenan, JT, Gadow, EC, Lopes, AC. Role of spontaneous abortion in Rh immunization. Am J Obstet Gynecol 1971;110:128–30.Google Scholar

Queenan, JT, Kubarych, SF, Shah, S, Holland, B. Role of induced abortion in rhesus immunisation. Lancet 1971;1:815–17.Google Scholar

Tabsh, KM, Lebherz, TB, Crandall, BF. Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis. Am J Obstet Gynecol 1984;149:225–6.Google Scholar

Brandenburg, H, Jahoda, MG, Pijpers, L, Wladimiroff, JW. Rhesus sensitization after midtrimester genetic amniocentesis. Am J Med Genet 1989;32:225–6.Google Scholar

Daffos, F, Capella-Pavlovsky, M, Forestier, F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol 1985;153:655–60.Google Scholar

Bowman, JM, Pollock, JM, Peterson, LE, et al. Fetomaternal hemorrhage following funipuncture: Increase in severity of maternal red-cell alloimmunization. Obstet Gynecol 1994;84:839–43.Google Scholar

Blakemore, KJ, Baumgarten, A, Schoenfeld-Dimaio, M, et al. Rise in maternal serum alpha-fetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization. Am J Obstet Gynecol 1986;155:988–93.Google Scholar

Jansen, MW, Brandenburg, H, Wildschut, HI, et al. The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels. Prenat Diagn 1997;17:953–9.Google Scholar

Rose, PG, Strohm, PL, Zuspan, FP. Fetomaternal hemorrhage following trauma. Am J Obstet Gynecol 1985;153:844–7.Google Scholar

Boucher, M, Marquette, GP, Varin, J, Champagne, J, Bujold, E. Fetomaternal hemorrhage during external cephalic version. Obstet Gynecol 2008;112:79–84.Google Scholar

An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis. Br J Obstet Gynaecol 1978;85 Suppl 2:1–41.Google Scholar

Simonovits, I, Timar, I, Bajtai, G. Rate of Rh immunization after induced abortion. Vox Sang 1980;38:161–4.Google Scholar

USPST Task Force. Screening for D (Rh) Incompatibility. In USPST Task Force Guide to Clinical Preventive Services 2nd ed. (Washington, DC: Office of Disease Prevention and Health Promotion, 1996).Google Scholar

Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 181: Prevention of Rh D alloimmunization. Obstet Gynecol 2017;130:e57–e70.Google Scholar

Moise KJ, Jr. , Gandhi, M, Boring, NH, et al. Circulating cell-free DNA to determine the fetal RHD status in all three trimesters of pregnancy. Obstet Gynecol 2016;128:1340–6.Google Scholar

Vivanti, A, Benachi, A, Huchet, FX, et al. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy. Am J Obstet Gynecol 2016;215:606e601–606 e605.Google Scholar

de Haas, M, Thurik, FF, van der Ploeg, CP, et al. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: Prospective cohort study of a nationwide programme in the Netherlands. BMJ 2016;355:i5789.Google Scholar

Sandler, SG, Flegel, WA, Westhoff, CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.Transfusion 2015;55:680–9.Google Scholar

Liley, AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol 1961;82:1359–70.Google Scholar

Queenan, JT, Tomai, TP, Ural, SH, King, JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks’ gestation: A proposal for clinical management. Am J Obstet Gynecol 1993;168:1370–6.Google Scholar

Mari, G, Deter, RL, Carpenter, RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9–14.Google Scholar

Zwiers, C, van Kamp, I, Oepkes, D, Lopriore, E. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn: Review on current management and outcome. Expert Rev Hematol 2017;10:337–44.Google Scholar

Lindenburg, IT, Smits-Wintjens, VE, van Klink, JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: The LOTUS study. Am J Obstet Gynecol 2012;206:141 e141-148.Google Scholar

Watson, WJ, Wax, JR, Miller, RC, Brost, BC. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. Am J Perinatol 2006;23:189–92.Google Scholar

Nicolaides, KH, Soothill, PW, Clewell, WH, et al. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988;1:1073–5.Google Scholar

Scheier, M, Hernandez-Andrade, E, Fonseca, EB, Nicolaides, KH. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol 2006;195:1550–6.Google Scholar

Papantoniou, N, Sifakis, S, Antsaklis, A. Therapeutic management of fetal anemia: Review of standard practice and alternative treatment options. J Perinat Med 2013;41:71–82.Google Scholar

Schumacher, B, Moise, KJ, Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137–50.Google Scholar

Lindenburg, IT, van Kamp, IL, van Zwet, EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation. BJOG 2013;120:847–52.Google Scholar

Vats, K, Watchko, JF. Coordinating care across the perinatal continuum in hemolytic disease of the fetus and newborn: The timely handoff of a positive maternal anti-erythrocyte antibody Screen. J Pediatr 2019;214:212–16.Google Scholar

Goplerud, CP, White, CA, Bradbury, JT, Briggs, TL. The first Rh-isoimmunized pregnancy. Am J Obstet Gynecol 1973;115:632–8.Google Scholar

Herschel, M, Karrison, T, Wen, M, Caldarelli, L, Baron, B. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 2002;110:127–30.Google Scholar

Cashore, WJ. Neonatal hyperbilirubinemia. In McMillan, JA, Feigin, RD, DeAngelis, CD, Jones, MDJ, eds. Oski’s Pediatrics 4th ed. (Philadelphia, PA: Lippincott, Williams & Wilkins; 2006), pp. 235–45.Google Scholar

Christensen, RD, Agarwal, AM, George, TI, Bhutani, VK, Yaish, HM. Acute neonatal bilirubin encephalopathy in the State of Utah 2009–2018. Blood Cells Mol Dis 2018;72:10–13.Google Scholar

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics 2004;114(4):1138]. Pediatrics 2004;114(1):297–316.Google Scholar

Alcock, GS, Liley, H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database of Systematic Reviews 2002;3:CD003313.Google Scholar

Zwiers, C, Scheffer-Rath, MEA, Lopriore, E, de Haas, M, Liley, HG. Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database of Systematic Reviews 2018;3:CD003313.Google Scholar

Watchko, JF. Emergency release uncross-matched packed red blood cells for immediate double volume exchange transfusion in neonates with intermediate to advanced acute bilirubin encephalopathy: Timely but insufficient? J Perinatol 2018;38:947–53.Google Scholar

Blackall, DP, Pesek, GD, Montgomery, MM, et al. Hemolytic disease of the fetus and newborn due to anti-Ge3: Combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition. Am J Perinatol 2008;25:541–5.Google Scholar

Dorn, I, Schlenke, P, Hartel, C. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: No evidence for anti-D-related suppression of erythropoiesis in vitro. Transfusion 2010;50:1064–70.Google Scholar

Rath, ME, Smits-Wintjens, VE, Lindenburg, IT, et al. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang 2011;100:312–16.Google Scholar

Bhutani, VK, Zipursky, A, Blencowe, H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013;74 Suppl 1:86–100.Google Scholar

Osaro, E, Charles, AT. Rh isoimmunization in sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies. Int J Womens Health 2010;2:429–37.Google Scholar

Kancherla, V, Oakley, GP, Jr., Brent, RL. Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med 2014;19:153–60.Google Scholar

Waldron, P, de Alarcón, P. ABO hemolytic disease of the newborn: A unique constellation of findings in siblings and review of protective mechanisms in the fetal-maternal system. Am J Perinatol 1999;16:391–8.Google Scholar

Sherer, DM, Abramowicz, JS, Ryan, RM, et al. Severe fetal hydrops resulting from ABO incompatibility. Obstet Gynecol 1991;78:897–9.Google Scholar

Lacey, PA, Caskey, CR, Werner, DJ, Moulds, JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23:91–4.Google Scholar

Bowman, JM, Pollock, JM, Manning, FA, Harman, CR. Severe anti-C hemolytic disease of the newborn. Am J Obstet Gynecol 1992;166:1239–43.Google Scholar

Macher, S, Wagner, T, Rosskopf, K, et al. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis. Transfusion 2016;56:80–3.Google Scholar

Malik, S, Moiz, B. Clinical significance of maternal anti-Cw antibodies: A review of three cases and literature. J Pak Med Assoc 2012;62:620–1.Google Scholar

Grobel, RK, Cardy, JD. Hemolytic disease of the newborn due to anti-EW. A fourth example of the Rh antigen, EW. Transfusion 1971;11:77–8.Google Scholar

Jakobowicz, R, Whittingham, S, Barrie, JU, Simmons, RT. A further investigation on polyvalent anti-C (rh’) and anti-G (rhg) antibodies produced by iso-immunization in pregnancy. Med J Aust 1962;49(1):896–7.Google Scholar

Li, BJ, Jiang, YJ, Yuan, F, Ye, HX. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17. Transfus Med 2010;20:66–9.Google Scholar

Vaughan, JI, Warwick, R, Welch, CR, Letsky, EA. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991;98:944–5.Google Scholar

Moncharmont, P, Juron-Dupraz, F, Doillon, M, Vignal, M, Debeaux, P. A case of hemolytic disease of the newborn infant due to anti-K (Cellano). Acta Haematol 1991;85:45–6.Google Scholar

Bowman, JM, Harman, FA, Manning, CR, Pollock, JM. Erythroblastosis fetalis produced by anti-k. Vox Sang 1989;56:187–9.Google Scholar

Duguid, JKM, Bromilow, IM. Haemolytic disease of the newborn due to anti-k. Vox Sang 1990;58:69–72.Google Scholar

Moulds, JM, Persa, R, Rierson, D, et al. Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American. Transfusion 2013;53:2867–71.Google Scholar

Jovanovic-Srzentic, S, Djokic, M, Tijanic, N, et al. Antibodies detected in samples from 21,730 pregnant women. Immunohematology 2003;19:89–92.Google Scholar

Mittal, K, Sood, T, Bansal, N, et al. Clinical significance of rare maternal anti Jk(a) antibody. Indian J Hematol Blood Transfus. 2016;32:497–9.Google Scholar

Ishida, A, Ohto, H, Yasuda, H, et al. Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol 2015;37:e375–377.Google Scholar

Wu, KH, Chu, SL, Chang, JG, Shih, MC, Peng, CT. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfus Med 2003;13:311–14.Google Scholar

Telischi, M, Behzad, O, Issitt, PD, Pavone, BG. Hemolytic disease of the newborn due to anti-N. Vox Sang 1976;31:109–16.Google Scholar

Moncharmont, P, Buclet, D, Trouilloud, C, Peyrard, T, Rigal, D. Severe hemolytic disease of the fetus and the newborn associated with anti-Vw (Vw). J Matern Fetal Neonatal Med 2010;23:1066–8.Google Scholar

Field, TE, Wilson, TE, Dawes, BJ, Giles, CM. Haemolytic disease of the newborn due to anti-Mt a. Vox Sang 1972;22:432–7.Google Scholar

Cheung, CC, Challis, D, Fisher, G, et al. Anti-Mta associated with three cases of hemolytic disease of the newborn. Immunohematology 2002;18:37–9.Google Scholar

Wu, KH, Chang, JG, Lin, M, et al. Hydrops foetalis caused by anti-Mur in first pregnancy–a case report. Transfus Med 2002;12:325–7.Google Scholar

Brooks, S, Squires, JE. Hemolytic disease of the fetus and newborn caused by anti-Lan. Transfusion. 2014;54:1317–20.Google Scholar

Davies, J, Day, S, Milne, A, Roy, A, Simpson, S. Haemolytic disease of the foetus and newborn caused by auto anti-LW. Transfus Med 2009;19:218–19.Google Scholar

Francis, BJ, Hatcher, DE. Hemolytic disease of the newborn apparently caused by anti-Lu-a. Transfusion 1961;1:248–50.Google Scholar

Scheffer, H, Tamaki, HT. Anti-Lu-b and mild hemolytic disease of the newborn: A case report. Transfusion 1966;6:497–8.Google Scholar

Dube, VE, Zoes, CS. Subclinical hemolytic disease of the newborn associated with IgG anti-Lub. Transfusion 1982;22:251–3.Google Scholar

Abhyankar, S, Silfen, S, Rao, SP, Vinciguerra, C, Dimiaio, TM. Positive cord blood “DAT” due to anti-Le(a): Absence of hemolytic disease of the newborn. Am J Pediatr Hematol Oncol 1989;11:184–5.Google Scholar

Carreras Vescio, LA, Torres, OW, Virgilio, OS, Pizzolato, M. Mild hemolytic disease of the newborn due to anti-Lewis(a). Vox Sang 1993;64:194–5.Google Scholar

Bharucha, ZS, Joshi, SR, Bhatia, HM. Hemolytic disease of the newborn due to anti-Le. Vox Sang 1981;41:36–9.Google Scholar

Reid, ME, Ellisor, SS. Hemolytic disease of newborn due to anti-Leb. Vox Sang 1982;42:278.Google Scholar

Joshi, SR, Wagner, FF, Vasantha, K, Panjwani, SR, Flegel, WA. An AQP1 null allele in an Indian woman with Co(a-b-) phenotype and high-titer anti-Co3 associated with mild HDN. Transfusion 2001;41:1273–8.Google Scholar

Sacks, DA, Johnson, CS, Platt, LD. Isoimmunization in pregnancy to Gerbich antigen. Am J Perinatol 1985;2:208–10.Google Scholar

Pate, LL, Myers, JC, Palma, JP, et al. Anti-Ge3 causes late-onset hemolytic disease of the newborn: The fourth case in three Hispanic families. Transfusion 2013;53:2152–7.Google Scholar

DeMarco, M, Uhl, L, Fields, L, et al. Hemolytic disease of the newborn due to the Scianna antibody, anti-Sc2. Transfusion 1995;35:58–60.Google Scholar

Rauch, S, Ritgen, J, Wisskirchen, M, et al. A case of anti-Rd causing fetal anemia. Transfusion 2017;57:1485–7.Google Scholar

Nakajima, H, Ito, K. An example of anti-Jra causing hemolytic disease of the newborn and frequency of Jra antigen in the Japanese population. Vox Sang 1978;35:265–7.Google Scholar

Masumoto, A, Masuyama, H, Sumida, Y, Segawa, T, Hiramatsu, Y. Successful management of anti-Jra alloimmunization in pregnancy: A case report. Gynecol Obstet Invest 2010;69:81–3.Google Scholar

Takabayashi, T, Murakami, M, Yajima, H, et al. Influence of maternal antibody anti-Jra on the baby: A case report and pedigree chart. Tohoku J Exp Med 1985;145:97–101.Google Scholar

Ishihara, Y, Miyata, S, Chiba, Y, Kawai, T. Successful treatment of extremely severe fetal anemia due to anti-Jra alloimmunization. Fetal Diagn Ther 2006;21:269–71.Google Scholar

Braschler, T, Vokt, CA, Hustinx, H, et al. Management of a pregnant woman with anti-holley alloantibody. Transfus Med Hemother 2015;42:129–30.Google Scholar

Ferguson, SJ, Boyce, F, Blajchman, MA. Anti-Ytb in pregnancy. Transfusion 1979;19:581–2.Google Scholar

Moulds, MK. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Technol 1981;47:789–95.Google Scholar

Maayan-Metzger, A, Schwartz, T, Sulkes, J, Merlob, P. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis. Arch Dis Child Fetal Neonatal Ed 2001;84:F60–62.Google Scholar

Cohen, DN, Johnson, MS, Liang, WH, McDaniel, HL, Young, PP. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG. Transfusion 2014;54:2863–6.Google Scholar

Pearson, HA. Life-span of the fetal red blood cell. J Pediatr 1967;70(2):166–71.Google Scholar

Oski, FA, Naiman, JL. Hematologic Problems in the Newborn, 3rd ed. (Philadelphia, PA: W. B. Saunders, 1982), pp. 1–360.Google Scholar

Matovcik, LM, Mentzer, WC. The membrane of the human neonatal red cell. Clin Haematol 1985;14(1):203–21.Google Scholar

Matovcik, LM, Chiu, D, Lubin, B, et al. The aging process of human neonatal erythrocytes. Pediatr Res 1986;20(11):1091–6.Google Scholar

Advani, R, Mentzer, W, Andrews, D, Schrier, S. Oxidation of hemoglobin F is associated with the aging process of neonatal red blood cells. Pediatr Res 1992;32(2):165–8.Google Scholar

Widness, JA, Kuruvilla, DJ, Mock, DM, et al. autologous infant and allogeneic adult red cells demonstrate similar concurrent post-transfusion survival in very low birth weight neonates. J Pediatr 2015;167(5):1001–6.Google Scholar

Kuruvilla, DJ, Widness, JA, Nalbant, D, et al. Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities. Pediatr Res 2017;81(6):905–10.Google Scholar

Geaghan, SM. Hematologic values and appearances in the healthy fetus, neonate, and child. Clin Lab Med 1999;19(1):1–37, v.Google Scholar

Holroyde, CP, Oski, FA, Gardner, FH. The pocked erythrocyte red-cell surface alterations in reticuloendothelial immaturity of the neonate. N Engl J Med 1969;281(10):516–20.Google Scholar

Padmanabhan, J, Risemberg, HM, Rowe, RD Howell-Jolly bodies in the peripheral blood of full-term and premature neonates. Johns Hopkins Med J 1973;132(3):146–50.Google Scholar

Maisels, MJ, Pathak, ANelson, NM, Nathan, DG, Smith, CA. Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J Clin Invest 1971;50(1):1–8.Google Scholar

Arias, IM. The pathogenesis of physiologic jaundice of the newborn: A reevaluation. Birth Defects Orig Artic Ser 1970;6(2):55–9.Google Scholar

Bhutani, VK, Johnson, L, Sivieri, EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103(1):6–14.Google Scholar

Necheles, TF, Rai, US, Valaes, T. The role of haemolysis in neonatal hyperbilirubinaemia as reflected in carboxyhaemoglobin levels. Acta Paediatr Scand 1976;65(3):361–7.Google Scholar

Coburn, RF, Williams, WJ, Kahn, SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966;45(4):460–8.Google Scholar

Coburn, RF. Endogenous carbon monoxide production. N Engl J Med 1970;282(4):207–9.Google Scholar

Smith, DW, Inguillo, D, Martin, D, et al. Use of noninvasive tests to predict significant jaundice in full-term infants: Preliminary studies. Pediatrics 1985;75(2):278–80.Google Scholar

Stevenson, DK, Vreman, HJ. Carbon monoxide and bilirubin production in neonates. Pediatrics 1997;100(2 Pt 1):252–4.Google Scholar

Salmi, TT Haptoglobin levels in the plasma of newborn infants with special reference to infections. Acta Paediatr Scand Suppl 1973;241:1–55.Google Scholar

Freda, VJ, Gorman, JG, Pollack, W, Bowe, E. Prevention of Rh hemolytic disease–ten years’ clinical experience with Rh immune globulin. N Engl J Med 1975;292(19):1014–16.Google Scholar

Baumann, R, Rubin, H. Autoimmune hemolytic anemia during pregnancy with hemolytic disease in the newborn. Blood 1973;41(2):293–7.Google Scholar

Hocking, DR. Neonatal haemolytic disease due to dapsone. Med J Aust 1968;1(26):1130–1.Google Scholar

Durocher, JR, Payne, RC, Conrad, ME. Role of sialic acid in erythrocyte survival. Blood 1975;45(1):11–20.Google Scholar

Batton, DG, Amanullah, A, Comstock, C. Fetal schistocytic hemolytic anemia and umbilical vein varix. J Pediatr Hematol Oncol 2000;22(3):259–61.Google Scholar

Oski, FA, Barness, LA. Vitamin E deficiency:a previously unrecognized cause of hemolytic anemia in the premature infant. J Pediatr 1967;70(2):211–20.Google Scholar

Ritchie, JH, Fish, MB, McMasters, V, Grossman, M. Edema and hemolytic anemia in premature infants A vitamin E deficiency syndrome. N Engl J Med 1968;279(22):1185–90.Google Scholar

Gomez-Pomar, E, Hatfield, E, Garlitz, K, Westgate, PM, Bada, HS. Vitamin E in the preterm infant: A forgotten cause of hemolytic anemia. Am J Perinatol 2018;35(3):305–10.Google Scholar

Smith, H. Normal Values and Appearances: Diagnosis in Paediatric Haematology (New York: Churchill Livingstone, 1996) p. 338.Google Scholar

Tuffy, P, Brown, AK, Zuelzer, WW. Infantile pyknocytosis: A common erythrocyte abnormality of the first trimester. AMA J Dis Child 1959;98(2):227–41.Google Scholar

Zannos-Mariolea, L, Kattamis, C, Paidoucis, M. Infantile pyknocytosis and glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 1962;8:258–65.Google Scholar

Keimowitz, R, Desforges, JF. Infantile pyknocytosis. N Engl J Med 1965;273(21):1152–4.Google Scholar

Ackerman, BD. Infantile pyknocytosis in Mexican-American infants. Am J Dis Child 1969;117(4):417–23.Google Scholar

Dabbous, IA, El Bahlawan, L. Infantile pyknocytosis: A forgotten or a dead diagnosis? J Pediatr Hematol Oncol 2002;24(6):507.Google Scholar

Eyssette-Guerreau, S, Bader-Meunier, B, Garcon, L, Guitton, C, Cynober, T. Infantile pyknocytosis: A cause of haemolytic anaemia of the newborn. Br J Haematol 2006; 133(4):439–2.Google Scholar

Dahoui, HA, Abboud, MR, Saab, R, et al. Familial infantile pyknocytosis in association with pulmonary hypertension. Pediatr Blood Cancer 2008;51(2):290–2.Google Scholar

Kraus, D, Yacobovich, J, Hoffer, V, et al. Infantile pyknocytosis: A rare form of neonatal anemia. Isr Med Assoc J 2010;12(3):188–9.Google Scholar

Vos, MJ, Martens, D, van de Leur, SJ, van Wijk, R. Neonatal hemolytic anemia due to pyknocytosis. Eur J Pediatr 2014;173(12):1711–14.Google Scholar

Rees, C, Lund, K, Bain, BJ. Infantile pyknocytosis. Am J Hematol 2019;94(4):489–90.Google Scholar

Gallagher, PG. Abnormalities of the erythrocyte membrane. Pediatr Clin North Am 2013;60(6):1349–62.Google Scholar

Gallagher, PG, Glader, B. Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane. In Greer, JP, Rodgers, GM, Glader, B, et al., eds. Wintrobe’s Clinical Hematology (Philadelphia PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2019), pp. 720–41.Google Scholar

Morton, NE, Mackinney, AA, Kosower, N, Schilling, RF, Gray, MP. Genetics of spherocytosis. Am J Hum Genet 1962;14:170–84.Google Scholar

Perrotta, S, Gallagher, PG, Mohandas, N . Hereditary spherocytosis. Lancet 2008;372(9647):1411–26.Google Scholar

Agre, P, Asimos, A, Casella, JF McMillan, C. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 1986;315(25):1579–83.Google Scholar

Eber, SW, Pekrun, A, Neufeldt, A, Schroter, W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: Screening using a modified glycerol lysis test. Ann Hematol 1992;64(2):88–92.Google Scholar

Palek, J, Jarolim, P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 1993;30(4):249–83.Google Scholar

Stamey, CC, Diamond, LK. Congenital hemolytic anemia in the newborn: Relationship to kernicterus. AMA J Dis Child 1957;94(6):616–22.Google Scholar

Trucco, JI, Brown, AK. Neonatal manifestations of hereditary spherocytosis. Am J Dis Child 1967;113(2):263–70.Google Scholar

Rubins, J, Young, LE. Hereditary spherocytosis and glucose-6-phosphate dehydrogenase deficiency. JAMA 1977;237(8):797–8.Google Scholar

49. Christensen, RD, Yaish, HM, Gallagher, PG. A pediatrician’s practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics 2015;135(6):1107–14.Google Scholar

King, MJ, Behrens, J, Rogers, C, et al. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000;111(3):924–33.Google Scholar

Christensen, RD, Agarwal, AM, Nussenzveig, RH, et al. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants. J Perinatol 2015;35(5):357–61.Google Scholar

Agarwal, AM, Nussenzveig, RH, Reading, NS, et al. Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. Br J Haematol 2016;174(5):806–14.Google Scholar

Andolfo, I, Russo, R, Gambale, A, Iolascon, A. New insights on hereditary erythrocyte membrane defects. Haematologica 2016;101(11):1284–94.Google Scholar

Iolascon, A, Faienza, MF, Moretti, A, Perrotta, S, Miraglia del Giudice, E. UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood 1998;91(3):1093.Google Scholar

Gallagher, PG, Petruzzi, MJ, Weed, SA, et al. Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest 1997;99(2):267–277.Google Scholar

Delhommeau, F, Cynober, T, Schischmanoff, PO, et al. Natural history of hereditary spherocytosis during the first year of life. Blood 2000;95(2):393–7.Google Scholar

Diamond, LK. Splenectomy in childhood and the hazard of overwhelming infection. Pediatrics 1969;43(5):886–9.Google Scholar

Tracy, ET, Rice, HE. Partial splenectomy for hereditary spherocytosis. Pediatr Clin North Am 2008;55(2):503–19, x.Google Scholar

Niss, O, Chonat, S, Dagaonkar, N, et al. Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis 2016;61:4–9.Google Scholar

Austin, RF, Desforges, JF. Hereditary elliptocytosis: An unusual presentation of hemolysis in the newborn associated with transient morphologic abnormalities. Pediatrics 1969;44(2):196–200.Google Scholar

MacDougall, LG, Moodley, G, Quirk, M. The pyropoikilocytosis-elliptocytosis syndrome in a black South African infant: Clinical and hematological features. Am J Pediatr Hematol Oncol 1982;4(3):344–9.Google Scholar

Mentzer, WC, Jr, Iarocci, TA, Mohandas, N, et al. Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in the neonatal poikilocytosis/elliptocytosis syndrome. J Clin Invest 1987;79(3):943–9.Google Scholar

Luzzatto, L, Nannelli, C, Notaro, R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am 2016;30(2):373–93.Google Scholar

Grace, RF, Glader, B. Red blood cell enzyme disorders. Pediatr Clin North Am 2018;65(3):579–95.Google Scholar

Glader, B, Grace, RF. Hereditary hemolytic anemias due to red blood cell enzyme disorders. In Greer, JP, Rodgers, GM, Glader, B, et al., eds. Wintrobe’s Clinical Hematology (Philadelphia PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2019), pp. 742–61.Google Scholar

Glader, B. Hereditary hemolytic anemias due to red blood cell enzyme disorders. In Greer, JP, Foerster, J, Lukens, JN, et al., eds. Wintrobe’s Clinical Hematology (Philadelphia PA: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2003).Google Scholar

Cappellini, MD, Fiorelli, G Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371(9606):64–74.Google Scholar

WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67:601–11.Google Scholar

Beutler, E. The molecular biology of enzymes of erythrocyte metabolism. In Stamatoyannopoulos, G, ed. The Molecular Basis of Blood Diseases (Philadelphia PA: W.B. Saunders, 2001).Google Scholar

Jiang, W, Yu, G, Liu, P, et al. Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population. Hum Genet 2006;119(5):463–78.Google Scholar

Valaes, T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: Pathogenesis and global epidemiology. Acta Paediatr Suppl 1994;394:58–76.Google Scholar

Kaplan, M, Algur, N, Hammerman, C. Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2001;108(4):956–9.Google Scholar

Johnson, L, Bhutani, VK, Karp, K, Sivieri, EM, Shapiro, SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009;29(Suppl 1):S25–45.Google Scholar

Bienzle, U, Effiong, C, Luzzatto, L. Erythrocyte glucose 6-phosphate dehydrogenase deficiency (G6PD type A–) and neonatal jaundice. Acta Paediatr Scand 1976;65(6):701–3.Google Scholar

Kaplan, M, Hammerman, C, Feldman, R, Brisk, R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2000;105(3 Pt 1):533–7.Google Scholar

Kaplan, M, Hammerman, C, Beutler, E. Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome. Eur J Pediatr 2001;160(3):195.Google Scholar

Slusher, TM, Vreman, HJ, McLaren, DW, et al.Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995;126(1):102–8.Google Scholar

Oyebola, DD. Care of the neonate and management of neonatal jaundice as practised by Yoruba traditional healers of Nigeria. J Trop Pediatr 1983;29(1):18–22.Google Scholar

Mentzer, WC, Collier, E. Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid. J Pediatr 1975;86(4):565–7.Google Scholar

MacDonald, MG. Hidden risks: Early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency. Pediatrics 1995;96(4 Pt 1):734–8.Google Scholar

Kaplan, M, Hammerman, C. The need for neonatal glucose-6-phosphate dehydrogenase screening: A global perspective. J Perinatol 2009;29(Suppl1):S46–52.Google Scholar

Meloni, T, Forteleoni, G, Meloni, GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: The northern Sardinian experience. Acta Haematol 1992;87(1–2):29–31.Google Scholar

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297–316.Google Scholar

Lin, Z, Fontaine, JM, Freer, DE, Naylor, EW. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 2005;86(1–2):212–19.Google Scholar

Watchko, JF, Kaplan, M, Stark, AR, Stevenson, DK, Bhutani, VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol 2013;33:499.Google Scholar

Bhutani, VK, Kaplan, M, Glader, B, et al. Point-of-care quantitative measure of glucose-6-phosphate dehydrogenase enzyme deficiency. Pediatrics 2015;136(5):e1268–75.Google Scholar

Kaplan, M, Vreman, HJ, Hammerman, C, et al. Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol 1996;93(4):822–7.Google Scholar

Kappas, A, Drummond, GS, Valaes, T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001;108(1):25–30.Google Scholar

McCurdy, PR, Morse, EE. Glucose-6-phosphate dehydrogenase deficiency and blood transfusion. Vox Sang 1975;28(3):230–7.Google Scholar

Mimouni, F, Shohat, S, Reisner, SH. G6PD-deficient donor blood as a cause of hemolysis in two preterm infants. Isr J Med Sci 1986;22(2):120–2.Google Scholar

Kumar, P, Sarkar, S, Narang, A. Acute intravascular haemolysis following exchange transfusion with G-6-PD deficient blood. Eur J Pediatr 1994;153(2):98–9.Google Scholar

Grace, RF, Zanella, A, Neufeld, EJ, et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol 2015;90(9):825–30.Google Scholar

Grace, RF, Bianchi, P, van Beers, EJ, et al. Clinical spectrum of pyruvate kinase deficiency: Data from the Pyruvate Kinase Deficiency Natural History Study. Blood 2018;131(20):2183–92.Google Scholar

Beutler, E, Gelbart, T. Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population. Blood 2000;95(11):3585–8.Google Scholar

Carey, PJ, Chandler, J, Hendrick, A, et al. Prevalence of pyruvate kinase deficiency in northern European population in the north of England Northern Region Haematologists Group. Blood 2000;96(12):4005–6.Google Scholar

Zanella, A, Fermo, E, Bianchi, P, Chiarelli, LR, Valentini, G. Pyruvate kinase deficiency: The genotype-phenotype association. Blood Rev 2007;21(4):217–31.Google Scholar

Grace, RF, Layton, DM, Barcellini, W. How we manage patients with pyruvate kinase deficiency. Br J Haematol 2019;189:721–34.Google Scholar

Bowman, HS, McKusick, VA, Dronamraju, KR. Pyruvate kinase deficient hemolytic anemia in an Amish isolate. Am J Hum Genet 1965;17:1–8.Google Scholar

Rider, NL, Strauss, KA Brown, K, et al. Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: Longitudinal risk and disease management. Am J Hematol 2011;86(10):827–34.Google Scholar

Gallagher, PG, Glader, B. Diagnosis of pyruvate kinase deficiency. Pediatr Blood Cancer 2016;63(5):771–2.Google Scholar

Bianchi, P, Fermo, E, Glader, B, et al. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol 2019;94(1):149–61.Google Scholar

Hutton, JJ, Chilcote, RR, Glucose phosphate isomerase deficiency with hereditary nonspherocytic hemolytic anemia. J Pediatr 1974;85(4):494–7.Google Scholar

Schroter, W, Koch, HH, Wonneberger, B, et al. Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: A new variant (type Nordhorn;IClinical and genetic studies. Pediatr Res 1974;8(1):18–25.Google Scholar

Van Biervliet, JP, Van Milligen-Boersma, L, Staal, GE. A new variant of glucosephosphate isomerase deficiency (GPI-Utrecht). Clin Chim Acta 1975;65(2):157–65.Google Scholar

Ravindranath, Y, Paglia, DE, Warrier, I, et al. Glucose phosphate isomerase deficiency as a cause of hydrops fetalis. N Engl J Med 1987;316(5):258–61.Google Scholar

Xu, W, Beutler, E. The characterization of gene mutations for human glucose phosphate isomerase deficiency associated with chronic hemolytic anemia. J Clin Invest 1994;94(6):2326–9.Google Scholar

Vora, S. Isozymes of phosphofructokinase. Isozymes Curr Top Biol Med Res 1982;6:119–67.Google Scholar

Vora, S, DiMauro, S, Spear, D, Harker, D, Danon, MJ. Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency: New subtype of glycogen storage disease type VII. J Clin Invest 1987;80(5):1479–85.Google Scholar

Schneider, AS, Valentine, WN, Hattori, M, Heins, HL Jr. Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med 1965;272:229–35.Google Scholar

Valentine, WN, Hsieh, HS, Paglia, DE, et al. Hereditary hemolytic anemia: Association with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. Trans Assoc Am Physicians 1968;81:49–65.Google Scholar

Schneider, A, Westwood, B, Yim, C, et al. Triosephosphate isomerase deficiency: Repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families. Am J Hematol 1995;50(4):263–8.Google Scholar

112. Valentine, WN, Oski, FA, Paglia, DE, et al. Hereditary hemolytic anemia with hexokinase deficiency: Role of hexokinase in erythrocyte aging. N Engl J Med 1967;276(1):1–11.Google Scholar

Kanno, H. Hexokinase: Gene structure and mutations. Baillieres Best Pract Res Clin Haematol 2000;13(1):83–8.Google Scholar

Beutler, E. Red cell enzyme defects as nondiseases and as diseases. Blood 1979;54(1):1–7.Google Scholar

Beutler, E, Baranko, PV, Feagler, J, et al. Hemolytic anemia due to pyrimidine-5’-nucleotidase deficiency: Report of eight cases in six families. Blood 1980;56(2):251–5.Google Scholar

Paglia, DE, Valentine, WN. Hereditary and acquired defects in the pyrimidine nucleotidase of human erythrocytes. Curr Top Hematol 1980;3:75–109.Google Scholar

Paglia, DE, Valentine, WN, Keitt, AS, Brockway, RA, Nakatani, M. Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: Evidence for existence of thymidine nucleotidase in human erythrocytes. Blood 1983;62(5):1147–9.Google Scholar

Taher, AT, Weatherall, DJ, Cappellini, MD. Thalassaemia. Lancet 2018;391(10116):155–67.Google Scholar

Vichinsky, E. Advances in the treatment of alpha-thalassemia. Blood Rev 2012;26 Suppl 1:S31–34.Google Scholar

Piel, FB, Weatherall, DJ. The alpha-thalassemias. N Engl J Med 2014;371(20):1908–16.Google Scholar

Singh, SA, Sarangi, S, Appiah-Kubi, A, et al. Hb Adana (HBA2 or HBA1:c.179 G > A) and alpha thalassemia: Genotype-phenotype correlation. Pediatr Blood Cancer 2018;65(9):e27220.Google Scholar

Chui, DH, Waye, JS. Hydrops fetalis caused by alpha-thalassemia: An emerging health care problem. Blood 1998;91(7):2213–22.Google Scholar

Liang, ST, Wong, VC, So, WW, et al. Homozygous alpha-thalassaemia: Clinical presentation, diagnosis and management: A review of 46 cases. Br J Obstet Gynaecol 1985;92(7):680–4.Google Scholar

Beaudry, MA, Ferguson, DJ, Pearse, K, et al. Survival of a hydropic infant with homozygous alpha-thalassemia-1. J Pediatr 1986;108(5 Pt 1):713–16.Google Scholar

Bianchi, DW, Beyer, EC, Stark, AR, et al. Normal long-term survival with alpha-thalassemia. J Pediatr 1986;108 (5 Pt 1):716–18.Google Scholar

Singer, ST, Styles, L, Bojanowski, J, et al. Changing outcome of homozygous alpha-thalassemia:cautious optimism. J Pediatr Hematol Oncol 2000;22(6):539–42.Google Scholar

Chui, DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci 2005;1054:25–32.Google Scholar

Hsieh, FJ, Ko, TM, Chen, HY. Hydrops fetalis caused by severe alpha-thalassemia. Early Hum Dev 1992;29(1–3):233–6.Google Scholar

Guy, G, Coady, DJ, Jansen, V, Snyder, J, Zinberg, S. Alpha-thalassemia hydrops fetalis: Clinical and ultrasonographic considerations. Am J Obstet Gynecol 1985;153(5):500–4.Google Scholar

Stein, J, Berg, C, Jones, JA, Detter, JC. A screening protocol for a prenatal population at risk for inherited hemoglobin disorders: Results of its application to a group of Southeast Asians and blacks. Am J Obstet Gynecol 1984;150(4):333–41.Google Scholar

Glader, BE. Screening for anemia and erythrocyte disorders in children. Pediatrics 1986;78(2):368–9.Google Scholar

Chan, V, Ghosh, A, Chan, TK, Wong, V, Todd, D. Prenatal diagnosis of homozygous alpha thalassaemia by direct DNA analysis of uncultured amniotic fluid cells. Br Med J (Clin Res Ed) 1984;288(6427):1327–9.Google Scholar

Fucharoen, S, Winichagoon, P, Thonglairoam, V, et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: Experience from 100 pregnancies. Southeast Asian J Trop Med Public Health 1991;22(1):16–29.Google Scholar

Hsieh, FJ, Chang, FM, Ko, TM, Chen, HY Percutaneous ultrasound-guided fetal blood sampling in the management of nonimmune hydrops fetalis. Am J Obstet Gynecol 1987;157(1):44–9.Google Scholar

Jelin, AC, Sagaser, KG, Wilkins-Haug, L. Prenatal genetic testing options. Pediatr Clin North Am 2019;66(2):281–93.Google Scholar

Winichagoon, P, Sithongdee, S, Kanokpongsakdi, S, et al. Noninvasive prenatal diagnosis for hemoglobin Bart’s hydrops fetalis. Int J Hematol 2005;81(5):396–9.Google Scholar

Tungwiwat, W, Fucharoen, S, Fucharoen, G, Ratanasiri, T, Sanchaisuriya, K. Development and application of a real-time quantitative PCR for prenatal detection of fetal alpha(0)-thalassemia from maternal plasma. Ann N Y Acad Sci 2006;1075:103–7.Google Scholar

Ho, SS, Chong, SS, Koay, ES, et al. Noninvasive prenatal exclusion of haemoglobin Bart’s using foetal DNA from maternal plasma. Prenat Diagn 2009;30(1):65–73.Google Scholar

Hudecova, I, Chiu, RW. Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA. Best Pract Res Clin Obstet Gynaecol 2017;39:63–73.Google Scholar

Yates, A. Prenatal Screening and Testing for Hemoglobinopathy (Philadelphia PA: Wolters Kluwer, 2019).Google Scholar

Chik, KW, Shing, MM, Li, CK, et al. Treatment of hemoglobin Bart’s hydrops with bone marrow transplantation. J Pediatr 1998;132(6):1039–42.Google Scholar

Thornley, I, Lehmann, L, Ferguson, WS, et al. Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32(3):341–2.Google Scholar

Lucke, T, Pfister, S Durken, M. Neurodevelopmental outcome and haematological course of a long-time survivor with homozygous alpha-thalassaemia: Case report and review of the literature. Acta Paediatr 2005;94(9):1330–3.Google Scholar

Yi, JS, Moertel, CL, Baker, KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr 2009;154(5):766–8.Google Scholar

Derderian, SC, Jeanty, C, Walters, MC, Vichinsky, E, MacKenzie, TC. In utero hematopoietic cell transplantation for hemoglobinopathies. Front Pharmacol 2014;5:278.Google Scholar

Higgs, DR, Weatherall, DJ. The alpha thalassaemias. Cell Mol Life Sci 2009;66(7):1154–62.Google Scholar

Jomoui, W, Fucharoen, G, Sanchaisuriya, K, Nguyen, VH, Fucharoen, S. Hemoglobin Constant Spring among Southeast Asian populations: Haplotypic heterogeneities and phylogenetic analysis. PLoS One 2015;10(12):e0145230.Google Scholar

Sirilert, S, Charoenkwan, P, Sirichotiyakul, S, et al. Prenatal diagnosis and management of homozygous hemoglobin Constant Spring disease. J Perinatol 2019;39(7):927–33.Google Scholar

Olivieri, NF. The beta-thalassemias. N Engl J Med 1999;341(2):99–109.Google Scholar

Cunningham, MJ, Sankaran, VG, Nathan, DG Orkin, SH. The thalassemias. In Orkin, SH, Nathan, DG, Ginsburg, D, et al., eds. Nathan and Oski’s Hematology of Infancy and Childhood (Philadelphia PA: Saunders/Elsevier,2009).Google Scholar

Cao, A, Rosatelli, MC, Monni, G, Galanello, R. Screening for thalassemia: A model of success. Obstet Gynecol Clin North Am 2002;29(2):305–28, vi–vii.Google Scholar

Olivieri, NF, Muraca, GM, O’Donnell, A, et al.Studies in haemoglobin E beta-thalassaemia. Br J Haematol 2008;141(3):388–97.Google Scholar

Sirichotiyakul, S, Saetung, R, Sanguansermsri, T. Prenatal diagnosis of beta-thalassemia/Hb E by hemoglobin typing compared to DNA analysis. Hemoglobin 2009;33(1):17–23.Google Scholar

Vichinsky, EP, MacKlin, EA, Waye, J S, Lorey, F, Olivieri, NF. Changes in the epidemiology of thalassemia in North America: A new minority disease. Pediatrics 2005;116(6):e818–825.Google Scholar

Lorey, F, Cunningham, G, Shafer, F, Lubin, B, Vichinsky, E. Universal screening for hemoglobinopathies using high-performance liquid chromatography: Clinical results of 2.2 million screens. Eur J Hum Genet 1994;2(4):262–71.Google Scholar

Lenfant, C. The Management of Sickle Cell Disease (Bethesda MD: National Insitutes of Health, 2002).Google Scholar

Gaston, MH, Verter, J I, Woods, G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314(25):1593–99.Google Scholar

Michlitsch, J, Azimi, M, Hoppe, C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009;52(4):486–90.Google Scholar

Wethers, D, Pearson, HA, Gaston, M. Newborn screening for sickle cell disease and other hemoglobinopathies. Pediatrics 1989;89(5):813–14.Google Scholar

Koshy, M, Burd, L. Obstetric and gynecologic issues. In Embury, S, Hebbel, RP eds. Sickle Cell Disease: Basic Principles and Clinical Practice (New York: Raven Press, 1995), p. 689.Google Scholar

Villers, MS, Jamison, MG, De Castro, LM, James, AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 2008;199(2):125,e121–5.Google Scholar

Williamson, D. The unstable haemoglobins. Blood Rev 1993;7(3):146–63.Google Scholar

Carrell, RW, Kay, R. A simple method for the detection of unstable haemoglobins. Br J Haematol 1972;23(5):615–19.Google Scholar

Lee-Potter, JP, Deacon-Smith, RA, Simpkiss, MJ, Kamuzora, H, Lehmann, H. A new cause of haemolytic anaemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 tryptophan yields glycine. J Clin Pathol 1975;28(4):317–20.Google Scholar

Charache, S, Mondzac, AM, Gessner, U. Hemoglobin Hasharon (alpha-2–47 his(CD5;beta-2): A hemoglobin found in low concentration. J Clin Invest 1969;48(5):834–47.Google Scholar

Levine, RL, Lincoln, DR, Buchholz, WM, Gribble, TJ Schwartz, HC. Hemoglobin Hasharon in a premature infant with hemolytic anemia. Pediatric Research 1975;9(1):7–11.Google Scholar

Bender, JW, Reilly, MP Asakura, T. Molecular stability and function of hemoglobins Hasharon (alpha(2)47 (CD5)Asp–His beta 2) and Hasharon (alpha(2)47 (CD5)Asp–His delta 2). Hemoglobin 1984;8(1):61–73.Google Scholar

Martin, H, Huisman, TH. Formation of ferrihaemoglobin of isolated human haemoglobin types by sodium nitrite. Nature 1963;200:898–9.Google Scholar

Bartos, HR, Desforges, JF. Erythrocyte DPNH dependent diaphorase levels in infants. Pediatrics 1966;37(6):991–3.Google Scholar

Comly, HH. Cyanosis in infants caused by nitrates in well water. J Am Med Assoc 1945;129(2):112–16.Google Scholar

Gelperin, A, Jacobs, EE, Kletke, LS. The development of methemoglobin in mothers and newborn infants from nitrate in water supplies. IMJ Ill Med J 1971;140(1):42–4 passim.Google Scholar

Keating, JP, Lell, ME, Strauss, AW, Zarkowsky, H, Smith, GE. Infantile methemoglobinemia caused by carrot juice. N Engl J Med 1973;288(16):824–6.Google Scholar

Yano, SS, Danish, EH, Hsia, YE. Transient methemoglobinemia with acidosis in infants. J Pediatr 1982;100(3):415–18.Google Scholar

Avner, JR, Henretig, FM, McAneney, CM. Acquired methemoglobinemia: The relationship of cause to course of illness. Am J Dis Child 1990;144(11):1229–30.Google Scholar

Kay, MA, O’Brien, W, Kessler, B, et al. Transient organic aciduria and methemoglobinemia with acute gastroenteritis. Pediatrics 1990;85(4):589–92.Google Scholar

Pollack, ES, Pollack, CV, Jr. Incidence of subclinical methemoglobinemia in infants with diarrhea. Ann Emerg Med 1994;24(4):652–6.Google Scholar

Hanukoglu, A, Danon, PN. Endogenous methemoglobinemia associated with diarrheal disease in infancy. J Pediatr Gastroenterol Nutr 1996;23(1):1–7.Google Scholar

Wessel, DL, Adatia, I, Van Marter, LJ, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997;100(5):E7.Google Scholar

Climie, CR, McLean, S, Starmer, GA, Thomas, J. Methaemoglobinaemia in mother and foetus following continuous epidural analgesia with prilocaine: Clinical and experimental data. Br J Anaesth 1967;39(2):155–160.Google Scholar

Law, RM, Halpern, S, Martins, RF, et al. Measurement of methemoglobin after EMLA analgesia for newborn circumcision. Biol Neonate 1996;70(4):213–17.Google Scholar

Tush, GM, Kuhn, RJ. Methemoglobinemia induced by an over-the-counter medication. Ann Pharmacother 1996;30(11):1251–4.Google Scholar

Brisman, M, Ljung, BM, Otterbom, I, Larsson, LE, Andreasson, SE. Methaemoglobin formation after the use of EMLA cream in term neonates. Acta Paediatr 1998;87(11):1191–4.Google Scholar

Essink-Tebbes, CM, Wuis, EW, Liem, KD, van Dongen, RT, Hekster, YA. Safety of lidocaine-prilocaine cream application four times a day in premature neonates:a pilot study. Eur J Pediatr 1999;158(5):421–3.Google Scholar

Kearns, GL, Fiser, DH. Metoclopramide-induced methemoglobinemia. Pediatrics 1988;82(3):364–6.Google Scholar

Hjelt, K, Lund, JT, Scherling, B, et al. Methaemoglobinaemia among neonates in a neonatal intensive care unit. Acta Paediatr 1995;84(4):365–70.Google Scholar

Percy, MJ, McFerran, NV, Lappin, TR. Disorders of oxidised haemoglobin. Blood Rev 2005;19(2):61–8.Google Scholar

Percy, MJ, Lappin, TR. Recessive congenital methaemoglobinaemia: Cytochrome b(5; reductase deficiency. Br J Haematol 2008;141(3):298–308.Google Scholar

Kutlar, F, Hilliard, LM, Zhuang, L, et al. Hb M Dothan [beta 25/26 (B7/B8)/(GGT/GAG-->GAG//Gly/Glu-->Glu]; a new mechanism of unstable methemoglobin variant and molecular characteristics. Blood Cells Mol Dis 2009;43(3):235–8.Google Scholar

Hayashi, A, Fujita, T, Fujimura, M, Titani, K. A new abnormal fetal hemoglobin, Hb FM-Osaka (alpha 2 gamma 2 63His replaced by Tyr). Hemoglobin 1980;4(3–4):447–8.Google Scholar

Glader, BE, Zwerdling, D, Kutlar, F, et al. Hb F-M-Osaka or alpha 2 G gamma 2 (63)(E7)His ----Tyr in a Caucasian male infant. Hemoglobin 1989;13(7–8):769–73.Google Scholar

Priest, JR, Watterson, J, Jones, RT, Faassen, AE, Hedlund, BE. Mutant fetal hemoglobin causing cyanosis in a newborn. Pediatrics 1989;83(5):734–6.Google Scholar

Harley, JD, Celermajer, JM. Neonatal methaemoglobinaemia and the red-brown screening-test. Lancet 1970;2(7685):1223–5.Google Scholar

Wood, JL. Plethora in the newborn infant associated with cyanosis and convulsions. J Pediatr 1952;54:143–51.Google Scholar

Michael, AF, Mauer, AM. Maternal-fetal transfusion as a cause of plethora in the neonatal period. Pediatrics 1961;28:458–61.Google Scholar

Minkowski, A. Acute cardiac failure in connection with neonatal polycythemia (in monovular twins and single newborn infants). Biol Neonate 1962;4:61–74.Google Scholar

Danks, DM, Stevens, LH. Neonatal respiratory distress with a high hematocrit. Lancet 1964;2:499–500.Google Scholar

Gross, GP, Hathaway, WE, McGaughey, HR. Hyperviscosity in the neonate. J Pediatr 1973;82:1004–12.Google Scholar

Ramamurthy, RS, Brans, YW. Neonatal polycythemia. I. Criteria for diagnosis and treatment. Pediatrics 1981;68:168–74.Google Scholar

Oh, W, Lind, J. Venous and capillary hematocrit in newborn infants and placental transfusion. Acta Paediatr Scand 1966;55:38–40.Google Scholar

Wirth, FH, Goldberg, KE, Lubchenco, LO. Neonatal hyperviscosity. I. Incidence. Pediatrics 1979;63:833–6.Google Scholar

Stevens, K, Wirth, FH. Incidence of neonatal hyperviscosity at sea level. J Pediatr 1980;97:118–19.Google Scholar

Brooks, GI, Backes, CR. Hyperviscosity secondary to polycythemia in the appropriate for gestational age neonate. J Am Obstet Assoc 1981;80:415–18.Google Scholar

Reisner, SH, Mor, N, Levy, Y, Merlob, P. Incidence of neonatal polycythemia. Isr J Med Sci 1983;19:848–9.Google Scholar

Oh, W, Oh, MA, Lind, J. Renal function and blood volume in newborn infants related to placental transfusion. Acta Paediatr Scand 1966;56:197–210.Google Scholar

Oh, W, Blankenship, W, Lind, J. Further study of neonatal blood volume in relation to placental transfusion. Ann Paediatr 1996;207:147–59.Google Scholar

Yao, AC, Moinian, M, Lind, J. Distribution of blood between infants and placenta after birth. Lancet 1969;2:871–3.Google Scholar

Linderkamp, O. Placental transfusion: determinants and effects. Clin Perinatol 1982; 9:559–92.Google Scholar

McDonald, SJ, Midddleton, P, Dowswell, T, Morris, PS. Cochrane in context: Effect of timing of umbilical cord clamping in term infants on maternal and neonatal outcomes. Evidence-based child Health: A Cochrane Review Journal 2014:9:198–400.Google Scholar

Shohat, M, Teisner, SH, Mimoini, F, Merlob, P. Neonatal polycythemia. II. Definition related to time of sampling. Pediatrics 1984;73:11–13.Google Scholar

Poiseuille, JLM. Recherches experimentales sur le mouvement des liquides dans les tubes de tres petits diametres. C R Acad Sci 1840;11:961–1041.Google Scholar

Van der Elst, CW, Malan, AF, de V Heese H, . Blood viscosity in modern medicine. S Afr Med J 1977;52:526–8.Google Scholar

Wells, RE, Pento, R, Merrill, EW. Measurements of viscosity of biologic fluids by core plate viscometer. J Lab Clin Med 1961;57:646–56.Google Scholar

Wells, RE, Merrill, EW. Influence of flow properties of blood upon viscosity–hematocrit relationships. J Clin Invest 1961;41:1591–8.Google Scholar

Dintenfass, L. Blood viscosity, internal fluidity of the red cell, dynamic coagulation and the critical capillary radius as factors in the physiology and pathology of circulation and microcirculation. Med J Aust 1968;1:688–96.Google Scholar

Linderkamp, O, Versmold, HT, Riegel, KP, Betke, K. Contributions of red cells and plasma to blood viscosity in preterm and full-term infants and adults. Pediatrics 1984;74:45–51.Google Scholar

Burton, AC. Role of geometry, of size and shape, in the microcirculation. Fed Proc 1966;25:1753–60.Google Scholar

Bergqvist, G. Viscosity of the blood in the newborn infants. Acta Paediatr Scand 1974; 63:858–64.Google Scholar

Wells, R. Syndromes of hyperviscosity. N Engl J Med 1970;283:183–6.Google Scholar

Somer, T, Ditze, J. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenstrom’s macroglobulinemia. Bibl Haematol 1981;47:242–6.Google Scholar

Charm, SE, Kurland, GS. Blood Flow and Microcirculation (New York: John Wiley & Sons, 1974).Google Scholar

Smith, CM, Prasler, WJ, Tukey, DP, et al. Fetal red cells are more deformable than adult red cells. Blood 1981;58:35a.Google Scholar

Linderkamp, O, Wu, PYK, Meiselman, HJ. Deformability of density separated red blood cells in normal newborn infants and adults. Pediatr Res 1982;16:964–8.Google Scholar

Lichtman, MA. Cellular deformability during maturation of the myeloblast. N Engl J Med 1970;283:943–8.Google Scholar

Lichtman, MA. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. J Clin Invest 1973;52:350–8.Google Scholar

Miller, ME. Developmental maturation of human neutrophil motility and its relationship to membrane deformability. In Bellanti, JA, Dayton, DH, eds. The Phagocytic Cell in Host Resistance (New York: Raven Press, 1975), p. 295.Google Scholar

Rand, PW, Austin, WH, Lacombe, E, Barker, N. pH and blood viscosity. J Appl Physiol 1968;25:550–9.Google Scholar

Fahraeus, R, Lindqvist, T. The viscosity of the blood in narrow capillary tubes. Am J Physiol 1931;96:562–8.Google Scholar

Nowicki, P, Oh, W, Yao, A, Hansen, NB, Stonestreet, SS. Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets. Am J Physiol 1984;247:G220–G225.Google Scholar

LeBlanc, MH, Kotagal, VR, Kleinman, LI. Physiological effects of hypervolemic polycythemia in newborn dogs. J Appl Physiol 1982;53:865–72.Google Scholar

Surjadhana, A, Rouleau, J, Boerboom, L, Hoffman, JIE. Myocardial blood flow and its distribution in anesthetized polycythemic dogs. Circ Res 1978;43:619–31.Google Scholar

Brashear, RE. Effects of acute plasma for blood exchange in experimental polycythemia. Respiration 1980;40:297–306.Google Scholar

Rosenkrantz, TS, Oh, W. Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial exchange transfusion with Plamanate. J Pediatr 1982;101:94–8.Google Scholar

Fouron, JC, Hebert, F. The circulatory effects of hematocrit variations in normovolemic newborn lambs. J Pediatr 1973;82:995–1003.Google Scholar

Gatti, RA, Muister, AJ, Cole, RB, Paul, MH. Neonatal polycythemia with transient cyanosis and cardiorespiratory abnormalities. J Pediatr 1966;69:1063–72.Google Scholar

Kotagal, VR, Keenan, WJ, Reuter, JH, et al. Regional blood flow in polycythemia and hypervolemia. Pediatr Res 1977;11:394A.Google Scholar

Swetnam, SM, Yabek, SM, Alverson, DC. Hemodynamic consequences of neonatal polycythemia. J Pediatr 1987;110:443–7.Google Scholar

Murphy, DJ, Jr., Reller, MD, Meyer, RA, Kaplan, S. Effects of neonatal polycythemia and partial exchange transfusion on cardiac function: An echocardiographic study. Pediatrics 1985;76:909–13.Google Scholar

Boehm, G, Delitzsch, AK, Senger, H, et al. Postnatal development of liver and exocrine pancreas in polycythemic newborn infants. J Pediatr Gastroenterol Nutr 1992; 15:310–14.Google Scholar

Kotagal, VR, Kleinman, LI. Effect of acute polycythemia on newborn renal hemodynamics and function. Pediatr Res 1982;16:14851.Google Scholar

Bergqvist, G, Zetterman, R. Blood viscosity and peripheral circulation in newborn infants. Acta Paediatr Scand 1974;63:865–8.Google Scholar

Linderkamp, O, Strohhacker, I, Versmold, HT, et al. Peripheral circulation in the newborn: Interaction of peripheral blood flow, blood pressure, blood volume and blood viscosity. Eur J Pediatr 1978;129:73–81.Google Scholar

Gustafsson, L, Applegren, L, Myrvold, HE. The effect of polycythemia on blood flow in working and non-working skeletal muscle. Acta Physiol Scand 1980;109:143–8.Google Scholar

Waffarn, F, Cole, CD, Huxtabl, RF. Effects of polycythemia and hyperviscosity on cutaneous blood flow and transcutaneous pO₂ and pCO₂ in neonate. Pediatrics 1984;74:389–94.Google Scholar

Jones, MD, Traystman, RJ, Simmons, MA, Molteni, RA. Effects of changes in arterial O2 content on cerebral blood flow in the lamb. Am J Physiol 1981;240:H209–H215.Google Scholar

Rosenkrantz, TS, Stonestreet, BS, Hansen, NB, et al. Cerebral blood flow in the newborn lamb with polycythemia and hyperviscosity. J Pediatr 1984;104:276–80.Google Scholar

Goldstein, M, Stonestreet, BS, Brann, BS, 4th, Oh, W. Cerebral cortical blood flow and oxygen metabolism in normocythemic hyperviscous newborn piglets. Pediatr Res 1988;24:486–9.Google Scholar

Rosenkrantz, TS, Philipps, AF, Skrzypczak, PS, Raye, JR. Cerebral metabolism in the newborn lamb with polythemia. Pediatr Res 1985;23:329–33.Google Scholar

Tenenbaum, DG, Piasecki, GJ, Oh, W, Rosenkrantz, TS, Jackson, BT. Fetal polycythemia and hyperviscosity: effect in umbilical blood flow and fetal oxygen consumption. Am J Obstet Gynecol 1983;147:48–51.Google Scholar

Saigal, S, Usher, RH. Symptomatic neonatal plethora. Biol Neonate 1977;32:62–72.Google Scholar

Sacks, MO. Occurrence of anemia and polycythemia in phenotypically dissimilar single ovum human twins. Pediatrics 1959;24:604–8.Google Scholar

Schwartz, JL, Maniscalco, WM, Lane, AT, Currao, WJ. Twin transfusion syndrome causing cutaneous erythropoiesis. Pediatrics 1984;74:527–9.Google Scholar

Philip, AGS, Yee, AB, Rosy, M, et al. Placental transfusion as an intrauterine phenomenon in deliveries complicated by fetal distress. Br Med J 1969;2:11–13.Google Scholar

Flod, NE, Ackerman, BD. Perinatal asphyxia and residual placental blood volume. Acta Paediatr Scand 1971;60:433–6.Google Scholar

Yao, AC, Lind, J. Effect of gravity on placental transfusion. Lancet 1969;2:505–6.Google Scholar

Oh, W, Omori, K, Emmanouilides, GC, Phelps, DI. Placenta to lamb fetus transfusion in utero during acute hypoxia. Am J Obstet Gynecol 1975;122:316–21.Google Scholar

Humbert, JR, Abelson, H, Hathaway, WE, Battaglia, FC. Polycythemia in small for gestational age infants. J Pediatr 1969;75:812–19.Google Scholar

Widness, JA, Garcia, JA, Oh, W, Schwartz, R. Cord serum erythropoietin values and disappearance rates after birth in polycythemic newborns. Pediatr Res 1982;16:218A.Google Scholar

Philipps, AF, Dubin, JW, Matty, PJ, Raye, JR. Arterial hypoxemia and hyperinsulinemia in the chronically hyperglycemic fetal lamb. Pediatr Res 1982;16:653–8.Google Scholar

Hod, M, Merlob, P, Friedman, S. Prevalence of congenital anomalies and neonatal complications in the offspring of diabetic mothers in Israel. Isr J Med Sci 1991;27:498–502.Google Scholar

Rosenkrantz, TS, Oh, W. Neonatal polycythemia and hyperviscosity. In Milunsky, A, Friedman, EA, Gluck, L, eds. Advances in Perinatal Medicine, vol. 5. (New York: Plenum Medical Book Co., 1986), pp. 93–123.Google Scholar

Hakanson, DO, Oh, W. Hyperviscosity in the small-for-gestational age infant. Biol Neonate 1980;37:109–12.Google Scholar

Rawlings, JS, Pettet, G, Wiswell, TE, Clapper, J. Estimated blood volumes in polycythemic neonates as a function of birth weight. J Pediatr 1982;101:594.Google Scholar

Brans, YW, Shannon, DL, Ramamurthy, RS. Neonatal polycythemia. II. Plasma, blood and red cell volume estimates in relation to hematocrit levels and quality of intrauterine growth. Pediatrics 1981;68:175–82.Google Scholar

Thorton, CJ, Shanno, DL, Hunter, MA, Ramamurthy, RS, Brans, YW. Body water estimates in neonatal polycythemia. J Pediatr 1983;102:113–17.Google Scholar

Oh, W, Wallgren, G, Hanson, JS, Lind, J. The effects of placental transfusion on respiratory mechanics of normal term newborn infants. Pediatrics 1967;40:6–12.Google Scholar

Scott, F, Evans, N. Distal gangrene in a polycythemic recipient fetus in twin-twin transfusion. Obstet Gynecol 1995;86:677–9.Google Scholar

Van der Elst, CW, Moteno, CD, Malan, AF, de V Heese, H. The management of polycythemia in the newborn infant. Early Hum Dev 1980;4:393–403.Google Scholar

Host, A, Ulrich, M. Late prognosis in untreated neonatal polycythemia with minor or no symptoms. Acta Paediatr Scand 1982;71:629–33.Google Scholar

Leake, RD, Thanopoulos, B, Nieberg, R. Hyperviscosity syndrome associated with necrotizing enterocolitis. Am J Dis Child 1975;129:1192–4.Google Scholar

Hakanson, DO, Oh, W. Necrotizing enterocolitis and hyperviscosity in the newborn infant. J Pediatr 1977;90:458–61.Google Scholar

Martinez-Tallo, E, Claure, N, Bancalari, E. Necrotizing entercolitis in full term or near term infants: Risk factors. Biol Neonate 1997;71:292–8.Google Scholar

LeBlanc, MH, D’Cruz, C, Pate, K. Necrotizing enterocolitis can be caused by polycythemic hyperviscosity in the newborn dog. J Pediatr 1984;105:804–9.Google Scholar

Black, VD, Rumack, CM, Lubchenco, LO, Koops, BL. Gastrointestinal injury in polycythemic term infants. Pediatrics 1985;76:225–31.Google Scholar

Herson, VC, Raye, JR, Rowe, JC, Philipps, AF. Acute renal failure associated with polycythemia in a neonate. J Pediatr 1982;100:137–9.Google Scholar

Leake, RD, Chan, GM, Zakauddin, S, et al. Glucose perturbation in experimental hyperviscosity. Pediatr Res 1980;14:1320–3.Google Scholar

Creswell, JS, Warburton, D, Susa, JB, et al. Hyperviscosity in the newborn lamb produces perturbation in glucose homeostasis. Pediatrics 1981;15:1348–50.Google Scholar

Rosenkrantz, TS, Philipps, AF, Knox, I, et al. Regulation of cerebral glucose metabolism in normal and polycythemic newborns. J Cereb Blood Flow Metab 1992;12:856–65.Google Scholar

Rivers, RPA. Coagulation changes associated with a high haematocrit in the newborn infant. Acta Paediatr Scand 1975;64:449–56.Google Scholar

Katz, J, Rodriquez, E, Mandini, G, Branson, HE. Normal coagulation findings, thrombocytopenia, and peripheral hemoconcentration in neonatal polycythemia. J Pediatr 1982;101:99–102.Google Scholar

Henriksson, P. Hyperviscosity of the blood and haemostasis in the newborn infant. Acta Paediatr Scand 1979;68:701–4.Google Scholar

Shaikh, BS, Erslev, AJ. Thrombocytopenia in polycythemic mice. J Lab Clin Med 1978; 92:765–71.Google Scholar

Jackson, CW, Smith, PJ, Edwards, CC, Whidden, MA. Relationship between packed cell volume, platelets and platelet survival in red blood cell-hypertransfused mice. J Lab Clin Med 1979;94:500–9.Google Scholar

Meberg, A. Transitory thrombocytopenia in newborn mice after intrauterine hypoxia. Pediatr Res 1980;14:1071–3.Google Scholar

Voorhies, TM, Lipper, EG, Lee, BCP, et al. Occlusive vascular disease in asphyxiated newborn infants. J Pediatr 1984;105:92.Google Scholar

Peters, M, Ten Cate, JW, Koo, LH, Breederveld, C. Persistent antithrombin III deficiency: Risk factor for thromboembolic complication in neonates small for gestational age. J Pediatr 1984;105:310–14.Google Scholar

Merchant, RH, Agarwal, MB, Joshi, NC, Parekh, SR. Neonatal polycythemia: A potentially serious disorder. Indian J Pediatr 1983;50:149–52.Google Scholar

Amit, M, Camfield, PR. Neonatal polycythemia causing multiple cerebral infarcts. Arch Neurol 1980;37:109–10.Google Scholar

Saggese, G, Bertelloni, S, Baroncelli, GI, et al. Elevated calcitonin gene related peptide in polycythemic newborn infants. Acta Pediatr 1992;81:966–8.Google Scholar

Alkalay, A, Pomerance, JJ, Prause, J, et al. Cholecalciferol metabolites in polycythemic newborns. Isr J Med Sci 1985;21:95–7.Google Scholar

Goldberg, K, Wirth, FH, Hathaway, WE. Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion. Pediatrics 1982;69:419–25.Google Scholar

Black, VD, Lubchenco, LD, Luckey, DW, et al. Developmental and neurologic sequelae of neonatal hyperviscosity syndrome. Pediatrics 1982;69:426–31.Google Scholar

Black, VD, Lubchenco, LO, Koops, BL, Poland, RL, Powell, DP. Neonatal hyperviscosity: Randomized study of effect of partial plasma exchange on long-term outcome. Pediatrics 1985;75:1048–53.Google Scholar

Black, VD, Camp, BW, Lubchenco, LO, et al. Neonatal hyperviscosity is associated with lower achievement and IQ scores at school age. Pediatr Res 1988;23:442A.Google Scholar

Bada, HS, Korones, SB, Pourcyrous, M, et al. Asymptomatic syndrome of polycythemic hyperviscosity: Effect of partial plasma exchange transfusion. J Pediatr 1992;120:579–85.Google Scholar

Dempsey, EM, Barrington, K. Short and long term outcomes following partial exchange transfusion in the polycythemic newborn: A systematic review. Arch Dis Child Fetal Neonatal Ed 2006;91(1):F2–F6.Google Scholar

Supapannachart, S, Siripoonya, P, Boonwattanasoontorn, W, Kanjanavanit, S. Neonatal polycythemia: Effects of partial exchange transfusion using fresh frozen plasma, Haemaccel and normal saline. Med Assoc Thai 1999;82(Suppl1):S82–S86.Google Scholar

Wong, W, Fok, TF, Lee, CH, et al. Randomised controlled trial: comparison of colloid or crystalloid for partial exchange transfusion for treatment of neonatal polycythaemia. Arch Dis Child Fetal Neonatal Ed 1997;77:F115–F118.Google Scholar

Glader, B. Erythrocyte disorders in infancy. In Schaffer, AJ, Avery, ME, eds. Diseases of the Newborn (Philadelphia, PA: W. B. Saunders, 1977), p. 625.Google Scholar

American Academy of Pediatrics Committee on Fetus and Newborn. Routine evaluation of blood pressure, hematocrit, and glucose in newborns. Pediatrics 1993;92:474–6.Google Scholar

Book contents

Section III - Erythrocyte Disorders

Summary

Access options

References

References

References

References

References

References

References

Book contents

Section III - Erythrocyte Disorders

Summary

Access options

References

References

References

References

References

References

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive